: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Pulmonary Hypertension, January 2026
Free Subscription

Abstracts
Retrieve all available abstracts of the following 498 articles:
HTML format

Single Articles

LIU C, Lu JW, Wu CH, Ho YJ, et al
Adjuvant Molecular Hydrogen Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report on Immunomodulatory Effects on Regulatory and Effector Lymphocytes.
In Vivo. 2026;40:551-560.
Abstract

XU W, Shen Y, Wan Z, Guo J, et al
Macrophage-driven immunopathology in pulmonary arterial hypertension: from mechanisms to targeted therapies.
Front Immunol. 2025;16:1721071.
Abstract

FERRARA F, Castaldo R, Gargani L, Benjamin N, et al
Predicting Exercise Pulmonary Hypertension: The RIGHT-NET Machine Learning model A Pilot Study.
Transl Res. 2025 Dec 30:S1931-5244(25)00121-5. doi: 10.1016/j.trsl.2025.
Abstract

DESHMUKH SN, Anand A, Deore SS
Haemodynamics and post-exercise recovery response in chronic obstructive pulmonary disease-pulmonary hypertension and interstitial lung disease-pulmonary hypertension: An appraisal.
Lung India. 2026;43:105-106.
Abstract

MALAKOUTIKHAH M, Kalantari F, Nematollahi A, Moradi H, et al
Severe pulmonary hypertension associated with unilateral pulmonary artery hypoplasia: A case report.
ARYA Atheroscler. 2025;21:1-7.
Abstract

MARTINEZ-SOLANO J, Bermejo-Fernandez J, Gonzalez-Mansilla A, Garcia-Orta R, et al
The role of the bone morphogenetic protein receptor 2 pathway in group 2 pulmonary hypertension secondary to valvular heart disease.
ERJ Open Res. 2025;11:00543-2025.
Abstract

J JB, R J, Murugan S, G SL, et al
Identification of upregulated genes in pulmonary hypertension using RNA sequencing profiling.
Bioinformation. 2025;21:3105-3109.
Abstract

TITZ A, Muller J, Schneider SR, Lichtblau M, et al
Comparison of Invasive Versus Non-Invasive Pulse Contour-Based Cardiac Output Measurements at Rest and During Exercise in Pulmonary Hypertension.
J Clin Med. 2025;14:8971.
Abstract

TITOLO AC, Ferrocino M, Biagi E, Rizzo L, et al
Neonatologist-Performed Echocardiography in Neonatal Pulmonary Hypertension: A Narrative Review of the Literature.
Diagnostics (Basel). 2025;15:3154.
Abstract

HUANG W, Zheng R, Gong L, Zhang Y, et al
Roles of Lipid Metabolism in Pulmonary Hypertension: Friend or Foe?
Biomolecules. 2025;15:1679.
Abstract

CSOMA B, Szucs G, Bikov A, Rozgonyi ZD, et al
Alveolar and Bronchial Nitric Oxide Parameters in Pre-Capillary Pulmonary Hypertension.
Biomedicines. 2025;13:2957.
Abstract

WANG M, Lu J, Li X, Xie H, et al
Construction of an early diagnostic model for pulmonary hypertension based on aging-related signature genes and identification of potential therapeutic targets.
Sci Rep. 2025;15:44788.
Abstract

LARSON J, Khorasani S, Laurenzo S, Chiu S, et al
Leveraging Vascular Over Ventricular Ratios in Observational Chronic Thromboembolic Pulmonary Hypertension and Acute Pulmonary Embolism Cohorts to Decode Clot Chronicity on Computed Tomography Angiography.
Pulm Circ. 2025;15:e70223.
Abstract

SANTACRUZ JC, Mantilla MJ, Pulido S, Agudelo C, et al
Pulmonary Hypertension in Systemic Lupus Erythematosus: Current Evidence and Future Directions.
Cureus. 2025;17:e97863.
Abstract

YAGDIRAN B, Uchehara CU, Safak A, Cekmen N, et al
The relationship between preoperative pulmonary hypertension risk in liver transplant and vascular and biliary complications in the postoperative period.
Diagn Interv Radiol. 2025 Dec 29. doi: 10.4274/dir.2025.253707.
Abstract

PARLAK ES, Uzun BAA, Gungor K, Ceylan EG, et al
Evaluation of Predisposing Factors and Coexisting Diseases in the Development of Chronic Thromboembolic Pulmonary Disease.
Clin Respir J. 2025;19:e70147.
Abstract

LIU Y, Deng X, He C, Lv S, et al
NDRG1-HIF1alpha interaction in hypoxic signaling for pulmonary hypertension.
Int J Biol Macromol. 2025;339.
Abstract

DUBLE EH, Springer CM, Koster LS
Association of pulmonary arterial end-diastolic forward flow and right heart remodeling in dogs with congenital pulmonic stenosis and precapillary pulmonary hypertension.
J Vet Cardiol. 2025;64:14-24.
Abstract

DZIKOWSKA-DIDUCH O, Dudzik-Niewiadomska I, Kurnicka K, Lichodziejewska B, et al
Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension.
Thromb J. 2025 Dec 27. doi: 10.1186/s12959-025-00818.
Abstract

JU G, Zhang S, Zhang J, Dong F, et al
Sodium Houttuyfonate Alleviates Monocrotaline-induced Pulmonary Hypertension by Regulating Canonical Transient Receptor Potential Channel Proteins.
Eur J Pharmacol. 2025 Dec 25:178507. doi: 10.1016/j.ejphar.2025.178507.
Abstract

HE R, Liu J, Tang X, Liu H, et al
Reversible Pulmonary Hypertension in CblC Deficiency (MMACHC c.80 A>G): long-term outcomes of metabolic and PH-targeted therapy.
Pediatr Res. 2025 Dec 26. doi: 10.1038/s41390-025-04720.
Abstract

ZHANG Y, Zhang Y, Yang S, Huang Y, et al
Risk prediction and therapeutic targets for incident pulmonary hypertension: a large-scale proteomic profiling and Mendelian randomization study.
Front Med. 2025 Dec 27. doi: 10.1007/s11684-025-1183.
Abstract

BUSCHULTE K, Kabitz HJ, Hagmeyer L, Hammerl P, et al
Baseline characteristics from the EXCITING-ILD registry.
BMJ Open Respir Res. 2025;12:e002902.
Abstract

CHEN M, He Y, Zhu X, Luo Y, et al
Baicalin attenuates pulmonary hypertension by targeting AMPK/CPT1A-mediated fatty acid metabolism.
Phytomedicine. 2025;150:157703.
Abstract

SONNICK MA, Laothamatas KC, Anderson MR, Stewart D, et al
Waitlist outcome differences for pulmonary hypertension patients are worse in the CAS era.
JHLT Open. 2025;11:100443.
Abstract

MACIAS PRADO FE, German Gaibor JM, Portaluppi Cervantes RE, Campozano Burgos MA, et al
Beyond Childhood: Percutaneous Closure of an Aortopulmonary Window with Severe Pulmonary Hypertension in an Adult Woman - A Case Report.
Interv Cardiol. 2025;20:e34.
Abstract

BEN DAVID R, Gurfinkel R, Nalbandyan K, Roth I, et al
[Pulmonary Tumor Thrombotic Microangiopathy - Case Report].
Harefuah. 2025;165:647-650.
Abstract

KERRIGAN WJ, Church AC, Herrick AL
Systemic Sclerosis-Recent Advances in Diagnosis and Management.
Br J Hosp Med (Lond). 2025;86:1-21.
Abstract

FUJIWARA M, Yamamura A, Miyaki R, Amano T, et al
Enhanced Yoda1-induced vasoconstriction in pulmonary arterial smooth muscle from monocrotaline-induced pulmonary hypertensive rats.
Biochem Biophys Res Commun. 2025;797:153183.
Abstract

NEWMAN J, Ghani H, Munagala S, Otter E, et al
The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients.
ERJ Open Res. 2025;11:00297-2025.
Abstract

GILLMEYER KR
Insights from the Pulmonary Hypertension Global Patient Survey: challenges in pulmonary hypertension care abound but so do opportunities.
ERJ Open Res. 2025;11:00963-2025.
Abstract

JENKIN I, Dimopoulos K, Nathan SD, Herbert S, et al
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype.
ERJ Open Res. 2025;11:00235-2025.
Abstract

MICKAEL C, Kabwe JC, Fonseca Balladares D, Bai AS, et al
Pulmonary Hypertension Associated With Sickle Cell Disease and Schistosomiasis.
Pulm Circ. 2025;15:e70230.
Abstract

LOKHANDWALA A, Salman Al-Timimi A, Da Silva T, Nourouzpour S, et al
Clinical implications of frailty in hospitalized patients with pulmonary arterial hypertension.
Chron Respir Dis. 2025;22:14799731251408844.
Abstract

DAGHER C, Akiki M, Swanson K, Carollo B, et al
Use of Sotatercept to Facilitate Transition From Intravenous to Oral Prostacyclin Therapy.
Clin Respir J. 2025;19:e70149.
Abstract

TAKITA Y, Morishita J, Park S, Goda A, et al
Mindfulness-Based Self-Management Program Using a Mobile Application for Patients with Pulmonary Hypertension: A Single-Arm Feasibility Study.
JMIR Cardio. 2025 Dec 16. doi: 10.2196/79639.
Abstract

WANG X, He Y, Li K, Xue Z, et al
TRAF6 mediates vascular remodeling via endoplasmic reticulum stress-mitophagy in hypoxic pulmonary hypertension.
Free Radic Biol Med. 2025 Dec 20:S0891-5849(25)01448.
Abstract

BEIS I, Dipla K, Haidich AB, Boutou A, et al
Safety and efficacy of exercise training in patients with pulmonary hypertension: a systematic review and meta-analysis.
Eur J Appl Physiol. 2025 Dec 22. doi: 10.1007/s00421-025-06104.
Abstract

SEEGER W
The Discovery of Inhaled Prostanoids for Pulmonary Hypertension.
Pulm Circ. 2025;15:e70192.
Abstract

LEE L, Cao S, Miles CB, Troy MP, et al
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.
Semin Intervent Radiol. 2025;42:509-517.
Abstract

MERK J, Yung D, Wright JN, Kapur RP, et al
Noncirrhotic Portopulmonary Hypertension Due to Hepatoportal Sclerosis in Adams-Oliver Syndrome.
Pediatrics. 2026;157:e2025073243.
Abstract

HU Y, Wang Y, Tan W, Zhao C, et al
Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial Hypertension.
J Med Chem. 2025;68:26547-26573.
Abstract

ZULFIQAR H, Alali J, Granlund B, Feng J, et al
Interleukin-35 alleviates pulmonary arterial hypertension by suppressing the VEGFA/VEGFR2 signaling pathway.
Life Sci. 2026;385:124144.
Abstract

ZHANG JY, Zhang R, Liu J, Chen L, et al
Agomelatine alleviates hypoxia-induced pulmonary arterial hypertension by activating mitophagy via the SIRT1/FoxO1/ULK1 signaling pathway.
Biochem Pharmacol. 2026;244:117624.
Abstract

WANG S, Song S, Feng H, Sun H, et al
tRF-31-PS5P4PW3FJHP inhibits hypoxia-induced proliferation of pulmonary artery endothelial cells by regulating EDN1 splicing via binding to LSM4.
Eur J Pharmacol. 2026;1011:178426.
Abstract

ZOLTY R
Antiproliferative therapies in pulmonary arterial hypertension.
Expert Opin Pharmacother. 2025;26:1895-1911.
Abstract

AHMAD A, Zhang S, Ren Q, Li L, et al
Transthoracic echocardiography of left ventricular underfilling improves risk stratification in pulmonary arterial hypertension.
Sci Rep. 2025;15:45718.
Abstract

MOSS ME, Smit MC, Klouda T, Zhao Z, et al
Pericytes and Lung Vascular Remodeling.
Arterioscler Thromb Vasc Biol. 2026;46:17-26.
Abstract

GARCIA KM, Hardie BA, Valdez-Jasso D
Sex-Specific Interventricular Septum Mechanics in Pulmonary Arterial Hypertension.
Ann Biomed Eng. 2026;54:29-40.
Abstract

BETTER J, Leroy S, Ninaber MK, Trakada G, et al
VE/VCO(2) at ventilatory threshold and peak VO(2) in CPET studies of patients with scleroderma-associated PAH: A systematic review and meta-analyses.
Autoimmun Rev. 2026;25:103942.
Abstract

SHI W, Chen L, Zhang W, He P, et al
YAP-mediated glycolysis promotes pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension.
J Biol Chem. 2025;301:110836.
Abstract

HUANG Y, Zhang C, Ye H, Sun X, et al
A Noninvasive Prognostic Model for Pulmonary Arterial Hypertension Associated With Connective Tissue Diseases Based on Multislice Chest Computed Tomography Parameters.
J Thorac Imaging. 2026;41:e0855.
Abstract

ZHOU L, Luo J, Tan C, Li Y, et al
Worldwide Burden of Pulmonary Arterial Hypertension in Adults Aged 65 Years and Older From 1990 to 2021.
J Am Geriatr Soc. 2025;73:3700-3707.
Abstract

TRUONG R, Davis S, Rosario N, Wollen J, et al
Sotatercept: A New Frontier in Pulmonary Arterial Hypertension Treatment.
Ann Pharmacother. 2026;60:163-174.
Abstract

POST TE, Denney C, Cohen A, Jordan J, et al
Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research.
Br J Clin Pharmacol. 2026;92:58-72.
Abstract

AKOPYAN K, Peterson J, Amoda O, Khasawneh M, et al
Echocardiographic Pulmonary Hypertension in Patients Positive for Myositis-Specific and Myositis-Associated Antibodies.
J Clin Med. 2025;15:77.
Abstract

KOOK H, Kim W, Heo R, Kim K, et al
Current Perspectives on Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
J Clin Med. 2025;15:51.
Abstract

ZHANG X, Chen M, Wang R, Liu R, et al
Flavonoids: Potential New Drug Candidates for Attenuating Vascular Remodeling in Pulmonary Hypertension.
Int J Mol Sci. 2025;27:210.
Abstract

IANCU DG, Cristescu L, Mares RG, Varga A, et al
Reply to Pagnoni et al. Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on "Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in
Diagnostics (Basel). 2025;16:56.
Abstract

PAGNONI G, Vicenzi A, Coppi F
Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypert
Diagnostics (Basel). 2025;16:55.
Abstract

ADU-AMANKWAAH J, Shi Y, Song H, Ma Y, et al
Correction: Signaling pathways and targeted therapy for pulmonary hypertension.
Signal Transduct Target Ther. 2026;11:12.
Abstract

ZHANG Y, Ye J, Chen J, Chen J, et al
Pharmacovigilance Analysis of Sotatercept for the Treatment of Pulmonary Arterial Hypertension Based on FAERS Database.
Cardiovasc Toxicol. 2026;26:12.
Abstract

VACHRUSHEV NS, Karpov AA, Shilenko LA, Vaulina DD, et al
Lung Tissue RNA Sequencing Shows Dysregulation of the Bronchial Epithelium in a Rat Model of Chronic Thromboembolic Pulmonary Hypertension.
Bull Exp Biol Med. 2026 Jan 9. doi: 10.1007/s10517-026-06549.
Abstract

PRISCO SZ, Kantorovich A, Liu Y, Sahay S, et al
Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey by the PVRI IDDI Access to Care Workstream.
Pulm Circ. 2026;16:e70229.
Abstract

DAOUD A, Lopez PP, Mombeini H, Zaeske A, et al
Echocardiographic Deformation Imaging of the Right Atrium: A New Paradigm in Noninvasive Hemodynamic Assessment.
Curr Cardiol Rep. 2026;28:11.
Abstract

KHAN SA, Parikh T, Rao A, Agrawal A, et al
In-hospital Mortality Patterns and Readmissions in Patients With Chronic Obstructive Pulmonary Disease: An Analysis of the Role of Pulmonary Hypertension.
COPD. 2026;23:2582902.
Abstract

SHIMOJO T, Tada T, Ito H, Kinoshita H, et al
Pulmonary tumour thrombotic microangiopathy or chronic thromboembolic pulmonary hypertension?-diagnosed by pulmonary wedge aspiration cytology using a Swan-Ganz catheter: a case report.
Eur Heart J Case Rep. 2025;10:ytaf648.
Abstract

ZHU Y, He J, Cai M, Wen L, et al
Safety of a novel portable inhaled nitric oxide generator for therapy of persistent pulmonary hypertension in neonates: a case series study.
Transl Pediatr. 2025;14:3305-3317.
Abstract

MIRZAMOHAMMADI S, Shirazi N, Deravi N, Zadeh RH, et al
Coronary Artery Calcium Score as a Potential Non-Invasive Marker for Pulmonary Artery Hypertension.
Acta Med Indones. 2025;57:445-453.
Abstract

WANG X, Song X, Yu F, Yu Y, et al
A Superoxide Anion-Responsive NIR Fluorogenic Probe Unravels Aucubin's Dual-Axis Therapeutic Mechanism in Hypoxic Pulmonary Hypertension via Ferroptosis Suppression and Oxidative Injury Mitigation.
Anal Chem. 2026 Jan 7. doi: 10.1021/acs.analchem.5c05233.
Abstract

KONDOH Y, Ogura T, Nishiyama O, Kinoshita H, et al
Corrigendum to "Long-term effects of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease" [Respir Invest, Volume 64, Issue 1, January 2026, 101340].
Respir Investig. 2026 Jan 6:101365. doi: 10.1016/j.resinv.2025.101365.
Abstract

SEERAM VK, Boppana LKT
Unilateral absence of pulmonary artery presenting with pulmonary hypertension in two adults.
BMJ Case Rep. 2026;19:e269028.
Abstract

ARTHUR ME, Mudaliar P, Sakharpe A, Odo N, et al
Between a Rock and a Hard Place: Hip Fracture Repair in an Elderly Patient with Severe Cardiac Comorbidities and Limited Options: A Problem-Based Learning Discussion.
A A Pract. 2026;20:e02058.
Abstract

VENKATESHVARAN A, Lindow T, Jumatate R, Kovacs A, et al
Linking Energetic Inefficiency to Ventriculoarterial Uncoupling in Pulmonary Hypertension.
Echocardiography. 2026;43:e70389.
Abstract

HAO J, Fang G, Li X, Wang T, et al
Targeting Macrophage Crosstalk to PASMC by Blunting Inflammatory Phenotype Via SerpinB1 Protects Against Hypoxia-Induced Pulmonary Hypertension.
Hypertension. 2026 Jan 7. doi: 10.1161/HYPERTENSIONAHA.125.25832.
Abstract

HUANG Y, Yan S, Zhu J, Zhang W, et al
SPP1 May Play an Important Role in the Carcinoid Nature of PAH.
Mediators Inflamm. 2025;2025:7457106.
Abstract

PAK O, Weissmann N
Is it the extracellular matrix?-smooth muscle fate in pulmonary hypertension secondary to left heart disease.
Cardiovasc Res. 2026 Jan 7:cvaf261. doi: 10.1093.
Abstract

LI G, Zhao Z, Machitani M, Ishikawa R, et al
Elucidation of mechanisms underlying the therapeutic effects of cordycepin on pulmonary hypertension, with a focus on cell senescence and gut microbiota.
Biomed Pharmacother. 2026;194:118923.
Abstract

YUE K, Qu X, Zhang F, Zhao M, et al
Pulmonary hypertension caused by fibrosing mediastinitis: A case report and literature review.
Medicine (Baltimore). 2026;105:e46180.
Abstract

KIM TH, Youn SE, Chung SH
Clinical impact of treprostinil in neonates with persistent pulmonary hypertension refractory to inhaled nitric oxide: A retrospective cohort study.
Medicine (Baltimore). 2026;105:e46984.
Abstract

BELKIN MN, Fudim M, Baratto C, Grinstein J, et al
Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
Circ Heart Fail. 2026 Jan 6:e000088. doi: 10.1161/HHF.0000000000000088.
Abstract

QIU Y, Lyu X, Zhang D, Xu H, et al
Gut Microbiota in Pulmonary Arterial Hypertension: Murine Models and Human Microbial Signatures, Pathogenic Mechanisms, and Emerging Therapeutic Avenues.
Compr Physiol. 2026;16:e70094.
Abstract

WANG Q, Liu J, Li R, Kong S, et al
Macrophage kappa-opioid receptor inhibits hypoxic pulmonary hypertension progression and right heart dysfunction via an SCD1-dependent anti-inflammatory response.
Genes Dis. 2025;13:101604.
Abstract

WANG M, Zhang M, Chen J, Wang Y, et al
Nuclear SIRT6 depletion activates LINE1-cGAS-STING pathway to induce PASMCs senescence in hypoxic pulmonary hypertension.
Cell Signal. 2026;139:112351.
Abstract

DING H, Zeng M, Sun B, Deng F, et al
Measurement of Pulmonary Artery Pressure in Rats Using Right Heart Catheterization.
J Vis Exp. 2025;.
Abstract

BAHMANI F, Pearce D, Southern K, Nwadiaro K, et al
Fluid Flow Analysis of Pulmonary Hypertension in End Stage Renal Disease: A NAMS-Driven Case Study.
J Biomech Eng. 2026 Jan 5:1-29. doi: 10.1115/1.4070760.
Abstract

HEGAZY Y, Abdallah A, Salem A, Assaker A, et al
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension.
Cureus. 2025;17:e98338.
Abstract

KURAHARA LH
[Cellular senescence in pulmonary hypertension].
Nihon Yakurigaku Zasshi. 2026;161:55-56.
Abstract

YOKOKAWA T, Nishiura K, Akama J, Kiko T, et al
Significance of 14-3-3 Epsilon for Right Ventricular Failure Associated with Pulmonary Hypertension.
Intern Med. 2026 Jan 2. doi: 10.2169/internalmedicine.6383.
Abstract

NAEEM A, Bolaji O, Kidess GG, Fahed J, et al
Durability of sotatercept response in pulmonary hypertension: Insights from extended real-world follow-up.
Int J Cardiol. 2026;447:134150.
Abstract

SOMECH J, Zahler D, St-Germain R, Roshdy O, et al
Rapidly reversible precapillary pulmonary hypertension in a patient with scurvy.
Can J Cardiol. 2026 Jan 2:S0828-282X(25)01621-6. doi: 10.1016/j.cjca.2025.
Abstract

BARANYAI T, Takacs P, Szabo B, Nagy Z, et al
[Balloon pulmonary angioplasty in Gottsegen National Cardiovascular Center - results of the first 2 years].
Orv Hetil. 2026;167:23-29.
Abstract

ROSHANZAMIR Z, Mohammadi F, Shirzadi R
Pulmonary hypertension in pediatric patients with cystic fibrosis during acute pulmonary exacerbations: prevalence and associated factors.
BMC Pulm Med. 2026 Jan 3. doi: 10.1186/s12890-025-04095.
Abstract

KAM THH, Kam KKH, Wong MKL, Yan BPY, et al
Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study.
BMC Pulm Med. 2026 Jan 3. doi: 10.1186/s12890-025-04069.
Abstract

HAN R, Wang Y, Lu X, Li W, et al
Comprehensive profiling of lactylation-associated genes in pulmonary hypertension through bulk and single-cell RNA sequencing integration.
Respir Res. 2026 Jan 3. doi: 10.1186/s12931-025-03446.
Abstract

GUAN A, Dai Z, Lin J, Chen Q, et al
Global disease burden of pulmonary arterial hypertension: patterns and inequality in 1990-2021, with projections to 2035.
BMC Public Health. 2026;26:4.
Abstract

LIU BY, Xie M
[Application and research progress of artificial intelligence in the diagnosis and treatment of rare lung diseases].
Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:78-83.
Abstract

MIHAI A
Right Ventricular Global Wasted Work and RV-PA Coupling: Implications for Pulmonary Hypertension.
Echocardiography. 2026;43:e70384.
Abstract

SPAGNOLO P, Dhanani Z, Cameli P, Fiorentu G, et al
Advanced Pulmonary Sarcoidosis.
Semin Respir Crit Care Med. 2025;46:564-575.
Abstract

QIAO X, Su D, Qin S, Shang L, et al
Pulmonary arterial hypertension increases the risk of female sexual dysfunction: a systematic review and meta-analysis.
J Sex Med. 2026;23:qdaf294.
Abstract

ZHI C, Shi X, Chen S, Cai Z, et al
Single-cell transcriptome analysis reveals critical causative candidates for Down syndrome-related lung diseases.
J Genet Genomics. 2026;53:75-86.
Abstract

MOU H, Zhang G, Xiu L, Zhao Q, et al
AI-assisted multimodal assessment for right ventricular function from echocardiography predicts mortality in patients with pulmonary hypertension and right heart failure.
Sci Rep. 2026 Jan 16. doi: 10.1038/s41598-026-36533.
Abstract

HERRERA-LEANO N, Sahay S, Benza RL, Barahona-Correa J, et al
Old Criteria, New Intelligence: The Evolution of ECG in Pulmonary Hypertension Diagnosis.
Respir Med. 2026 Jan 14:108646. doi: 10.1016/j.rmed.2026.108646.
Abstract

ZHANG J, Fan Y, Gao Y, Jin Y, et al
Histone deacetylase 3 promotes hypoxia-induced human pulmonary arterial smooth muscle cell proliferation by modulating the CSF2-JAK2-STAT5 signaling pathway.
Hum Cell. 2026;39:35.
Abstract

CADD M
Comment on "Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis".
Ann Card Anaesth. 2026;29:150-151.
Abstract

RASHID D, Zehra S
Comment on "Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.
Ann Card Anaesth. 2026;29:149-150.
Abstract

GODINAS L, Orlitova M, Muscogiuri E, Ceulemans L, et al
Lung transplantation for chronic thromboembolic pulmonary hypertension.
JHLT Open. 2025;11:100461.
Abstract

ZHANG P, Avazmohammadi R, Prins KW, Choudhary G, et al
Mechano-energetic uncoupling in the right ventricle in pulmonary hypertension.
JHLT Open. 2025;11:100460.
Abstract

LUCERO MJ, Setua S, Thangaraju K, Khan A, et al
Ferroportin Inhibition Attenuates Pulmonary Hypertension in Hypoxic Sickle Cell Disease Mice.
Blood Adv. 2026 Jan 15:bloodadvances.2025018680.
Abstract

PINTO OLIVEIRA C, Pascoal MD, Prata AR, Carvalho D, et al
Comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient.
Clin Exp Rheumatol. 2026 Jan 12. doi: 10.55563.
Abstract

ABOLWAFA A, Al-Lawati A, Al-Kindi HN, Zacharias S, et al
Surgical Strategies for Unilateral Pulmonary Artery Agenesis: A case series.
Sultan Qaboos Univ Med J. 2025;26:13-19.
Abstract

ALIYAR AA, Eldar AS, Sadig SA, Mubariz GT, et al
Advances in the Study of Bronchial and Vascular Architecture of Lungs in the Rat's Model: from Morphogenesis to Disease Modelling.
Cell Physiol Biochem. 2025;59.
Abstract

YANG Y, Zhang Y, Gong S, Liang N, et al
Pulmonary neuroendocrine cell as a therapeutic strategy in pulmonary hypertension: Great expectations or Bleak House?
Life Sci. 2026;388:124194.
Abstract

LIU K, Peng W, Yang X, Zeng Y, et al
Efficacy and Multi-Omics Regulatory Effects of Guilou Tongluo Formula in Patients with Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension: A Prospective, Multicenter, Randomized Controlled Trial.
J Ethnopharmacol. 2026 Jan 12:121204. doi: 10.1016/j.jep.2026.121204.
Abstract

KLOUDA T, Wong W, Fynn-Thompson F, Esch JJ, et al
Lung Transplantation and Reverse Potts Shunt for Pulmonary Hypertension in the Pediatric Population.
Pediatr Transplant. 2026;30:e70263.
Abstract

MENDES-FERREIRA P, Tielemans B, Wagenaar A, Bouzin C, et al
Beta-3 Adrenoreceptor Agonist Mirabegron Improves Right Ventricular Function in a Rat Monocrotaline-Induced Pulmonary Hypertension Model.
Pulm Circ. 2026;16:e70232.
Abstract

YUE X, Lan J, Yang L, Zhao L, et al
Curcumin-Loaded Tetrahedral Framework Nucleic Acids Alleviate Pulmonary Hypertension by Regulating Multiple Synergistic Signaling Pathways.
Adv Healthc Mater. 2026 Jan 13:e05281. doi: 10.1002/adhm.202505281.
Abstract

LI Y, Xing H, Liu Y, Li F, et al
Roles of the Altitude-Adapted Immune Microenvironment in Pulmonary Vascular Remodeling in High-Altitude Pulmonary Hypertension: A Review.
Med Sci Monit. 2026;32:e949962.
Abstract

LAKEW YB, Ahmed HY, Mulisa MD, Arega B, et al
Prevalence of pulmonary hypertension and its associated factors among chronic kidney disease patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: an institution-based retrospective study.
BMC Cardiovasc Disord. 2026 Jan 13. doi: 10.1186/s12872-026-05516.
Abstract

KAYSIN A, Swami S, Aluko O, Bultman DS, et al
Topics in Lung Disease: Pulmonary Hypertension.
FP Essent. 2025;559:7-15.
Abstract

LIU A, Du J, Li H, Xi L, et al
What is the difference between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension on phase-resolved functional lung MRI? A cross-sectional observational study.
Eur Radiol. 2026 Jan 13. doi: 10.1007/s00330-025-12271.
Abstract

LI J, Han P, Zhao X, Lan L, et al
Echocardiographic Analysis of Tricuspid Regurgitation and Other Hemodynamic Factors in Relation to Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Echocardiography. 2026;43:e70393.
Abstract

GUPTA S, Chopra D
Do Nails Tell a Pulmonary Tale? A Cross-Sectional Study on Psoriasis and Pulmonary Hypertension Risk.
J Cutan Med Surg. 2026 Jan 12:12034754251408375. doi: 10.1177/12034754251408375.
Abstract

GIAKAS AM, Milano ME, Gehret JA, Rihn JA, et al
Compressive cervicothoracolumbar epidural haematoma following lead insertion for spinal cord stimulator trial.
BMJ Case Rep. 2026;19:e268333.
Abstract

ZHANG J, Zhang W, Fan B, Yang Z, et al
Paeoniflorin Alleviates Pulmonary Arterial Hypertension by Suppressing TRIM24-Mediated SIRT1 Ubiquitination and NLRP3 Inflammasome Activation.
Chem Biol Drug Des. 2026;107:e70238.
Abstract

SHARMA A, Bilal Y, Yousaf I, Masuta P, et al
Pulmonary Hypertension in Rare Disease Overlap: Neurofibromatosis Type 1 Meets Sarcoidosis.
Cureus. 2025;17:e98767.
Abstract

BISCOTTI RODIL B, Duarte Torres J, Martin De Miguel I, Cruz Utrilla A, et al
Chronic Thromboembolic Pulmonary Hypertension Incidence, Post-pulmonary Embolism Syndrome and Possible Role of Transcatheter Therapy in Prevention.
Interv Cardiol. 2025;20:e37.
Abstract

ZHAO Y, Wang J, Qiao Y, Gai X, et al
Echinacoside Improves Pulmonary Vascular Remodeling by Regulating the L- and T-Type Ca(2+) Channels in the Prevention and Treatment of Pulmonary Hypertension.
Pulm Circ. 2026;16:e70235.
Abstract

CHEN A, Yan Y, Cao R, Cai K, et al
Zinc-Induced PKCdelta-dependent Phosphorylation of MTF-1 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension.
Int J Biol Sci. 2026;22:823-840.
Abstract

YUAN W, Tie H, Feng T, Zhang F, et al
Successful surgical intervention for Berry syndrome combined with severe pulmonary hypertension: a case description.
Quant Imaging Med Surg. 2026;16:100.
Abstract

TSOI SM, Parker C, Colglazier E, Cheung S, et al
The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
Pediatr Pulmonol. 2026;61:e71448.
Abstract

ZHAO L, Liu Y, Ou Z, Zhao X, et al
GLP-1 agonists reduce right ventricular mitochondrial dysfunction by inhibiting the GSK3beta-Drp1 signalling in pulmonary hypertension.
Eur J Med Res. 2026 Jan 10. doi: 10.1186/s40001-025-03815.
Abstract

CHEN J, Chen Y, Chen W, Tan Y, et al
Set7 regulates ferroptosis in pulmonary arterial hypertension endothelial cells through the DPP4/NOX4 axis mediated by H3K4me1 modification.
Cell Signal. 2026;139:112352.
Abstract

[Guidelines for the diagnosis and treatment of pulmonary arterial hypertension associated with adult congenital heart disease].
Zhonghua Xin Xue Guan Bing Za Zhi. 2026;54:9-38.
Abstract

CHEN X, Yan D, Liu C, Dai J, et al
The trend analysis and comparison of pulmonary arterial hypertension disease burden in China and India from 1990 to 2021: a study based on the Global Burden of Disease 2021 database.
Eur J Med Res. 2025;31:78.
Abstract

CETINKAYA C, Sagir A, Terzi A, Ermerak NO, et al
Sclerotherapy embolism: a novel etiology for chronic thromboembolic pulmonary disease.
BMC Pulm Med. 2025;26:14.
Abstract

ZHU Y, Wang X, Yan X, Sun Y, et al
Identification of potential biomarkers associated with mitochondrial oxidative stress in idiopathic pulmonary arterial hypertension via bioinformatic and experimental analysis.
Sci Rep. 2025;16:1647.
Abstract

ISHIHARA T, Kawamura G, Nagano M, Azuma S, et al
Successful use of methylene blue for severe vasoplegia in a patient with partially-treated portopulmonary hypertension with atrial septal defect undergoing liver transplantation: a case report.
BMC Anesthesiol. 2025;26:30.
Abstract

HUANG AP, Voskamp S, Ebadi AA, Liedel JL, et al
Meta-analysis of differential gene expression in idiopathic pulmonary arterial hypertension.
Cardiovasc Pathol. 2026;81:107805.
Abstract

WANG X, Li S, Hou J, Cao S, et al
tsRNA-3040b accumulates R-loop to regulate Trim35 transcription, which leads to disordered glycolysis and promotes PAECs proliferation.
Cell Mol Biol Lett. 2025;31:4.
Abstract

PRABHAKAR A, De Bie EM, DesJardin JT, Ghatpande P, et al
GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.
J Clin Invest. 2025;136:e199159.
Abstract

SEEDAHMED MI, Okereke J, Al-Qadi MO
Pulmonary hypertension in a distinct IgG4-high phenotype of sarcoidosis: A case series.
J Natl Med Assoc. 2026 Jan 22:S0027-9684(25)00363.
Abstract

CUETO-ROBLEDO G, Graniel-Palafox LE, Roldan-Valadez E
Pulmonary Hypertension Unmasking Unilateral Absence of the Pulmonary Artery in Congenital Scoliosis.
Mayo Clin Proc. 2026 Jan 23:S0025-6196(25)00507.
Abstract

LIU G, Tian H, Tan J, Liu Y, et al
Resistin-Like Molecule Beta Participates in Calcium Regulation Via Direct Interaction With CaSR and a PLC-IP(3)R-Dependent Mechanism in Hypoxia-Induced Pulmonary Hypertension.
Pulm Circ. 2026;16:e70247.
Abstract

ALNASSER TN, Hokmabadi A, Checkley EW, Sharkey MJ, et al
A fully automated explainable predictive model for diagnosing pre-capillary and post-capillary pulmonary hypertension on routine unenhanced CT: results from the ASPIRE registry.
Eur Heart J Digit Health. 2025;7:ztaf124.
Abstract

DOTEGUCHI S, Matsugi E, Takashima S, Kawai R, et al
Influence of Patient Characteristics on the Effectiveness of Inhaled Nitric Oxide Therapy for Pulmonary Hypertension Following Cardiac Surgery: A Post-marketing Surveillance in Japan.
Cureus. 2025;17:e99788.
Abstract

YU Z, Chen Y, Zhang M, Feng N, et al
Risk of Group 2 Pulmonary Hypertension in Newly Diagnosed Heart Failure: An EHR-Based Cohort Analysis.
medRxiv [Preprint]. 2025 Dec 9:2025.12.03.25341274.
Abstract

CAI C, Ni G, Chen L, Deng C, et al
Altitude hypoxia and hypoxemia: pathogenesis and management.
Signal Transduct Target Ther. 2026;11:27.
Abstract

BIONDI F, Ghelardoni S, Morrone D, De Caterina R, et al
Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis.
Vascul Pharmacol. 2026 Jan 20:107580. doi: 10.1016/j.vph.2025.107580.
Abstract

ADRIAN RJ, Eke OF, Al Jalbout N, Al Hariri M, et al
Pulmonary hypertension in cardiac tamponade: An observational cohort study of in-hospital mortality and echocardiographic findings.
Am J Emerg Med. 2026;102:55-61.
Abstract

HERTIG D, Lichtblau M, Furian M, Ulrich S, et al
[Acute high-altitude illnesses - Definition, Prophylaxis, Therapy].
Ther Umsch. 2025;82:209-214.
Abstract

YAMADA Y, Satoh T, Yaoita N, Yamada K, et al
Pathogenesis of Pulmonary Artery Remodeling: TGF-Beta Signaling and Inhibin Subunit Beta A in Group 1 and 2 Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2026 Jan 22. doi: 10.1161/ATVBAHA.125.322506.
Abstract

LIU J, Hou L, Yang J, Xu Z, et al
Development and Characterization of a Novel Chronic Thromboembolic Pulmonary Hypertension Rat Model: Identifying Sell-Podxl as Potential Regulators.
Hypertension. 2026 Jan 22. doi: 10.1161/HYPERTENSIONAHA.125.25589.
Abstract

IANNONE C, Stano S, Pellico MR, Cito A, et al
Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension.
Ther Adv Musculoskelet Dis. 2026;18:1759720X251410681.
Abstract

BECHER C, Groeneveld EJ, Quarck R, Neep B, et al
BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension.
Hypertension. 2026;83:e24916.
Abstract

JANKAUSKAS SS, Kansakar U, Varzideh F, Santulli G, et al
IL-33 Drives Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension.
Hypertension. 2026;83:e26356.
Abstract

CHEONG AP, Lam LT, Ng LH, Luk NHV, et al
Pulmonary Artery Denervation With Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation and Pulmonary Hypertension.
JACC Case Rep. 2026 Jan 2:106577. doi: 10.1016/j.jaccas.2025.106577.
Abstract

DAGHER C, Thomas A, Al Absi S, Carollo B, et al
Rapid Inpatient Uptitration of Inhaled Treprostinil in PH-ILD Patients with Severe Phenotype.
Adv Respir Med. 2026;94:7.
Abstract

TOCCI G, Santi M, Viola C, Pancani R, et al
Stress testing in the diagnosis and early screening of chronic thromboembolic pulmonary disease with and without pulmonary hypertension.
Eur J Clin Invest. 2026;56:e70175.
Abstract

RIZZO C, La Barbera L, Guggino G
Reply to the comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient.
Clin Exp Rheumatol. 2026 Jan 20. doi: 10.55563.
Abstract

SHYLLESH H A, Memon TA, Guruswamy P, Shekha TAM, et al
Pulmonary Alveolar Microlithiasis Coexisting With Rheumatic Heart Disease and Severe Pulmonary Hypertension: A Case Report.
Cureus. 2025;17:e99674.
Abstract

CHEN R, Ye W, Yang Y, Liao H, et al
Role of hsa-miR-122-5p in chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease: Targeting PIK3CG in the PI3K/Akt signaling pathway.
Medicine (Baltimore). 2026;105:e47210.
Abstract

CATALANI F, Valeriani E, Ageno W, Campello E, et al
Anticoagulation in chronic thromboembolic pulmonary hypertension: an updated systematic review and meta-analysis.
Intern Emerg Med. 2026 Jan 20. doi: 10.1007/s11739-025-04257.
Abstract

UPHUS JAG, Hu JR, Huang S, Hofbauer TM, et al
Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension.
Pulm Circ. 2026;16:e70246.
Abstract

SATOH A, Soyama A, Matsushima H, Kinoshita A, et al
Liver Transplantation for a Patient With Hemophilia and HIV/HCV Coinfection Complicated by Pulmonary Hypertension.
Hepatol Res. 2026 Jan 19. doi: 10.1111/hepr.70121.
Abstract

CUI XH, Yu LL, Yang M, Liu W, et al
Serum metabolomic profiles linking diabetes mellitus to pulmonary hypertension: a prospective cohort study with mediation analysis and risk prediction.
Respir Res. 2026 Jan 19. doi: 10.1186/s12931-026-03499.
Abstract

WREN JT JR, Joshi R, McNamara PJ
Navigating the Unique Challenge of Pulmonary Hypertension From Left-to-Right PDA Shunts in Two Cases of Congenital Diaphragmatic Hernia.
Echocardiography. 2026;43:e70396.
Abstract

ZHANG Z, Zhang X, Duan F, Song Z, et al
Efficacy and prognosis of multimodal angiography-interventions for chronic pulmonary artery stenosis and pulmonary hypertension.
Am J Transl Res. 2025;17:9956-9967.
Abstract

HERNANDEZ M, Winicki NM, Puerta CD, Lakshminarayanan S, et al
The NOTCH3 extracellular domain is a serum biomarker for pulmonary arterial hypertension.
Nat Med. 2026;32:306-317.
Abstract

MA C, Wang Z, Zhu X, Pang X, et al
Super enhancer-driven LINC01013 mediates hypoxia-induced mitochondrial dysfunction by HSPA9 to determine pulmonary arterial smooth muscle cell fate.
Cell Mol Life Sci. 2026;83:57.
Abstract

MORGAN C, Southgate L, Calder A, Sekar T, et al
SOX17 variants are associated with severe pulmonary arterial hypertension with and without congenital heart disease.
Int J Cardiol. 2026;447:134114.
Abstract

ALSALEH T, Harb A, Chapagain P, Dakkak B, et al
Prevalence and risk factors of portopulmonary hypertension in chronic liver disease: systematic review and meta-analysis.
Clin Res Hepatol Gastroenterol. 2026;50:102748.
Abstract

FERNANDEZ VALLONE V, Fischer K, Kuchler J, Diekmann F, et al
Generation of 5 hiPSC lines from pediatric patients with Heritable pulmonary arterial hypertension (HPAH) caused by heterozygous mutations in the TBX4 gene.
Stem Cell Res. 2026;90:103886.
Abstract

LI P, Zhang B, Wang J, Li W, et al
XLOC_010588 Promotes Mitophagy Via BAG2-Mediated PINK1 Stabilization in HPH.
Hypertension. 2026;83:e25742.
Abstract

FREYALDENHOVEN KJ, Johnson JA, Terrazas A, Alsaloum P, et al
Cardiopulmonary Outcomes in Sarcoidosis Patients with Ocular Involvement: A Propensity-Score-Matched Analysis.
Ocul Immunol Inflamm. 2026;34:64-72.
Abstract

TELLEZ L, Donate J, Guerrero A, Beraza IA, et al
Early portopulmonary hypertension predicts mortality in patients with cirrhosis: insights from the PORTO-DETECT cohort.
J Hepatol. 2025 Oct 9:S0168-8278(25)02490-0. doi: 10.1016/j.jhep.2025.
Abstract

CHILINGARASHVILI G, Mylvaganam RJ, Bernardo RJ, Shah A, et al
Sotatercept in Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension: A Case Series and Systematic Review.
Pulm Circ. 2026;16:e70239.
Abstract

ALTURAIF N, Alduraibi FK, Marquez K, Alahmadi F, et al
Pulmonary endarterectomy in antiphospholipid syndrome: a retrospective analysis from the Saudi pulmonary hypertension registry.
Front Med (Lausanne). 2026;13:1736115.
Abstract

KRONBERGER C, Mousavi RA, Ermolaev N, Poledniczek M, et al
Performance on the one-minute sit-to-stand test predicts long-term adverse outcomes in pulmonary hypertension.
Sci Rep. 2026 Jan 29. doi: 10.1038/s41598-026-37611.
Abstract

BERTHELOT E, Bauer F, Fauvel C, Paclot M, et al
Echocardiographic Risk Stratification in Heart Failure with Post-Capillary Pulmonary Hypertension: Prognostic Value of LAVI and TAPSE/PASP.
Eur Heart J Cardiovasc Imaging. 2026 Jan 30:jeag034. doi: 10.1093.
Abstract

PAGNONI G, Vicenzi A, Coppi F
Designing the right trial for sacubitril / valsartan in heart failure with preserved ejection fraction-related pulmonary hypertension.
Pol Arch Intern Med. 2026;136:17211.
Abstract

NIEMIEC M, Grabka M, Niemiec R, Filipecki A, et al
Designing the right trial for sacubitril / valsartan in heart failure with preserved ejection fraction-related pulmonary hypertension. Authors' reply.
Pol Arch Intern Med. 2026;136:17212.
Abstract

AHMED F, Haider F, Ali R, Arham M, et al
Comparative accuracy of artificial intelligence versus manual interpretation in detecting pulmonary hypertension across chest imaging modalities: a diagnostic test accuracy meta-analysis.
Front Artif Intell. 2026;8:1709489.
Abstract

KUMAR P, Verma AK, Bajpai J, Kar SK, et al
Pulmonary hypertension in patients with obstructive sleep apnea: Correlation with disease severity and quality of life.
World J Cardiol. 2026;18:112541.
Abstract

BAISYA R, Vardhan YK, Gsr M, Vardhan YV, et al
The Long-Term Outcomes of Pulmonary Hypertension in Systemic Lupus Erythematosus (SLE-PAH) Vary Among Different Autoantibody-Based Clusters: An Observational, Longitudinal Study Conducted at a Single Centre in India.
Mediterr J Rheumatol. 2025;36:594-599.
Abstract

VENKATESHVARAN A, Lindqvist P, Evaldsson AW
Right Ventricular Global Wasted Work: Employing Myocardial Energetics for Risk Assessment and Outcome Prediction in Pulmonary Hypertension.
Eur Heart J Cardiovasc Imaging. 2026 Jan 28:jeag029. doi: 10.1093.
Abstract

RONG C, Zhang L, Li B, Wang Y, et al
Efficacy and safety of specific treatment combined with SGLT2-i in pulmonary hypertension.
Front Cardiovasc Med. 2026;12:1684394.
Abstract

WANG H, Cui M
Effects of balloon pulmonary angioplasty on cardiac and pulmonary functions and complications in patients with chronic thromboembolic pulmonary hypertension.
Front Med (Lausanne). 2026;12:1689193.
Abstract

SHEN T, Lv X, Wang C, Ma Q, et al
Severe pulmonary edema after pulmonary hypertension interventional surgery: case report and literature review.
Front Med (Lausanne). 2026;12:1723147.
Abstract

SUEBLINVONG V, Chang SS, Ma J, Archer DR, et al
Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension.
Cells. 2026;15:154.
Abstract

TILEA I, Iancu DG, Fira-Mladinescu O, Bertici N, et al
Sotatercept in Pulmonary Arterial Hypertension: Molecular Mechanisms, Clinical Evidence, and Emerging Role in Reverse Remodelling.
Int J Mol Sci. 2026;27:767.
Abstract

BATUM O, Ayik Turk M, Varol Y, Ozyilmaz B, et al
Genetic and Clinical Determinants of Chronic Thromboembolic Pulmonary Hypertension: The Role of PAI-1 Polymorphism.
Int J Mol Sci. 2026;27:758.
Abstract

SCAGLIOLA R
Deciphering the Counterintuitive Role of Vascular Endothelial Growth Factor Signaling Pathways in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2026;27:687.
Abstract

MILANO G, Ottolenghi S, Zubieta-Calleja G, Beghetti M, et al
Mechanisms Underlying Altitude-Induced and Group 3 Pulmonary Hypertension.
Int J Mol Sci. 2026;27:572.
Abstract

YOKOYAMA YM, Watanabe R, Yamaguchi T, Ishihara R, et al
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.
Biomolecules. 2026;16:140.
Abstract

OKECHUKWU A, Odetunde O, Uchenna E, Chinawa JM, et al
Prevalence and severity of persistent pulmonary hypertension of the newborns among asphyxiated neonates admitted in Enugu State University Teaching Hospital.
BMJ Paediatr Open. 2026;10:e004351.
Abstract

AHMADIPOUR B, Pat S, Khajali F, Hassanpour H, et al
Effects of Sodium Butyrate Forms on Carcass Performance, Pulmonary Hypertension, Metabolic Health and Oxidative-Inflammatory Responses in Broiler Chickens Under Cold Stress at High Altitude.
Vet Med Sci. 2026;12:e70720.
Abstract

LIANG S, Wang X, Wu Y
Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.
Hum Exp Toxicol. 2026;45:9603271261420421.
Abstract

GARCIA SM, Lantz BJ, Wagner HJ, Jones DT, et al
Inducible Ift88-deficient mice show features consistent with mild pulmonary hypertension.
Physiol Rep. 2026;14:e70749.
Abstract

LECHUGA CG, Kachabi A, Colebank MJ, Korcarz CE, et al
Patient-Specific Lumped-Parameter Model for Quantifying Vessel-Specific Remodeling and Predicting Right Ventricular Function in Pulmonary Hypertension.
Compr Physiol. 2026;16:e70102.
Abstract

ZHANG H, Guo X, Han Y
A tale of two forces: pulmonary hypertension and hepatopulmonary syndrome in congenital portosystemic shunt.
Eur Heart J. 2026 Jan 13:ehaf820. doi: 10.1093.
Abstract

HUANG Y, Qin B, Shen B, Zhu J, et al
Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: A Comparative Study of Biomarkers and Clinical Indicators.
Pulm Circ. 2026;16:e70228.
Abstract

SU H, Li B, Guo Z, Zhang F, et al
Beta-Alanine Supplementation Ameliorates Right Ventricular Remodeling Caused by Monocrotaline-Induced Pulmonary Hypertension.
Pulm Circ. 2026;16:e70244.
Abstract

MA J, Cao X, Yang X, Zhu Y, et al
Natural products targeting the immune-metabolic regulatory network in pulmonary hypertension: mechanisms, classification, and therapeutic prospects.
Front Pharmacol. 2026;16:1712903.
Abstract

LU Z, Zhang C, Wan J, Xiao Y, et al
Exercise tolerance in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
Heart Lung. 2026;78:102725.
Abstract

YOKAWA K, Kawakami M, Tanaka Y, Higuma T, et al
Acute pulmonary hypertension induced by heparin-protamine complex during thoracoabdominal aortic grafting.
J Cardiothorac Surg. 2026 Jan 24. doi: 10.1186/s13019-025-03807.
Abstract

REVENKO SV, Tarakanov IA, Tikhomirova LN, Kuropatkina TA, et al
Effect of Hindlimb Denervation on Survival Rate and Circulation and Respiration Systems in Monocrotaline Rat Model of Pulmonary Arterial Hypertension.
Bull Exp Biol Med. 2025;179:644-649.
Abstract

CHEN H, Qiu YX, Xie YF, Chen X, et al
Redox switch C674 in SERCA2 triggers Ca(2+)-calcineurin-MCU-Drp1 cascade and pulmonary vascular remodeling.
Free Radic Biol Med. 2026;244:380-394.
Abstract

YU L, Hou Z, Han L, An Y, et al
Clinical and imaging characteristics of pulmonary artery dissection.
Int J Cardiovasc Imaging. 2026;42:111-117.
Abstract

OU L, Chen Y, Shen A, He S, et al
Epigenetically activated MIR100HG regulates UPF1-mediated oxidative stress to promote pulmonary vascular immune microenvironment remodeling.
Free Radic Biol Med. 2026;244:210-228.
Abstract

JIAO Q, Yang Y, Xu X, Hao J, et al
Therapeutic potential of magnesium diboride nanosheets in PAH-associated right heart failure: Integrated multi-omics analysis reveals ferroptosis suppression via LC3/ATG5/NCOA4/FTH1 pathway.
Free Radic Biol Med. 2026;244:1-16.
Abstract

QASEM U, Alghwyeen W, Alshqeirat M, Saman R, et al
Unveiling pleuropulmonary manifestations in systemic lupus erythematosus: a retrospective observational study from the Middle East.
Clin Rheumatol. 2026;45:151-162.
Abstract

HAYVACI CANBEYLI F, Secgen K, Ezgu FS, Tacoy G, et al
The Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Pediatr Cardiol. 2026;47:821-829.
Abstract

ELSABAN M, Radosevich MA, Pennington KM, Spencer PJ, et al
Cardiac Arrest in the Setting of Left Lung Herniation Following Combined Heart-Lung Transplant: Case Report.
ASAIO J. 2025;71:e168-e171.
Abstract

SATPATHY SK, Paswal CM, Gupta N, Soni JP, et al
Endomyocardial calcification with pulmonary and systemic hypertension in a term neonate with multisystem inflammatory syndrome of newborn (MIS-N).
BMJ Case Rep. 2026;19:e270053.
Abstract

WU C, Zhao W, Zhu X, Li Y, et al
Identification and genetic validation of potential therapeutic targets for pulmonary hypertension through multi-omics causal inference.
Medicine (Baltimore). 2026;105:e47525.
Abstract

A treprostinil inhaler (Yutrepia) for pulmonary hypertension.
Med Lett Drugs Ther. 2026;68:27-28.
Abstract

CHEN A, Chen Z, Huang B, Lian G, et al
Correction to: Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension.
Mol Cell Biochem. 2026 Feb 5. doi: 10.1007/s11010-026-05493.
Abstract

SUBEDI BK, Gautam N, Ali R, Tan IJ, et al
Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study.
Int J Rheum Dis. 2026;29:e70515.
Abstract

LI SS, Guo M, Zhao Y, Huang S, et al
circMFN2 Regulates the IGF2BP3-PDK4 to Ameliorate Pulmonary Hypertension.
Hypertension. 2026 Feb 5. doi: 10.1161/HYPERTENSIONAHA.125.25460.
Abstract

SUZUKI Y, Nagaoka T, Nagata Y, Terayama Y, et al
Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14- and CD163-Positive M2 Macrophages.
Respirology. 2026 Feb 4. doi: 10.1002/resp.70206.
Abstract

PAEZ-CARPIO A, Domenech-Ximenos B, Serrano E, Cornellas L, et al
Vascular Obstruction Scoring on Dual-energy CT, Cone-beam CT and Digital Subtraction Angiography: Correlation with Invasive Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension.
Acad Radiol. 2026 Feb 3:S1076-6332(26)00019-X. doi: 10.1016/j.acra.2026.
Abstract

LIU T, Zhou W, Fang C, Liang Y, et al
Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension.
Sci Transl Med. 2026;18:eadu6425.
Abstract

TAKITA Y, Morishita J, Park S, Goda A, et al
Mindfulness-Based Self-Management Program Using a Mobile App for Patients With Pulmonary Hypertension: Single-Arm Feasibility Study.
JMIR Cardio. 2026;10:e79639.
Abstract

ROQUE AC, Stockmann IS, Acencio MMP, Silva CSR, et al
IL-6 and TGF-beta1 as biomarkers of schistosomiasis-associated pulmonary hypertension in a murine model.
Braz J Med Biol Res. 2026;59:e15221.
Abstract

FILIPIAK J, Dzikowska-Diduch O, Justyna A, Labyk A, et al
How long does chronic thromboembolic pulmonary hypertension take to develop? Two cases of post?thrombotic complete occlusion of the left pulmonary artery.
Pol Arch Intern Med. 2026 Feb 3:17220. doi: 10.20452/pamw.17220.
Abstract

PLUNKETT MJ, Sayegh ALC, Lewis RA, McWilliams TJ, et al
Sympatho-Excitation in Pulmonary Hypertension: The Potential Role of Pulmonary Arterial Baroreceptors: An Acute Physiologic Intervention Study.
Respirology. 2026 Feb 3. doi: 10.1002/resp.70207.
Abstract

FENG W, Bai D, Mo S, Wen D, et al
Echinatin Alleviates Experimental Pulmonary Hypertension by PPARgamma Pathway Activation.
FASEB J. 2026;40:e71542.
Abstract

CHI L, Foley AE, Goodarzi G, Volchuk A, et al
The hypoxic tight-skin mouse model of Group 3 pulmonary hypertension.
Sci Rep. 2026 Feb 2. doi: 10.1038/s41598-026-38174.
Abstract

JIANG YH, Zhang ZL, Qin N, Luo XY, et al
[Role of macrophages in pulmonary arterial hypertension and advances in targeted therapeutic interventions].
Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:215-222.
Abstract

HOMEDI A, Ali Ali K, Almehaid A, Alrahili M, et al
Targeted Neonatal Echocardiography and Neonatal Hemodynamics in the Kingdom of Saudi Arabia: A One-Year Experience in Service Implementation.
Saudi Med J. 2026;47:60-66.
Abstract

BOCHENEK ML, Ghasemi I, Wiedenroth CB, Bikou O, et al
Transmembrane Protein 100 Expression on Endothelial Cells Vascularizing Thrombi in Chronic Thromboembolic Pulmonary Hypertension Modulates TGFbeta1-ALK1 Signaling During Angiogenesis.
Pulm Circ. 2026;16:e70253.
Abstract

MOREIRA-COSTA L, Leite-Moreira A, Adao R, Laville D, et al
A swine model of severe chronic thromboembolic pulmonary hypertension induced by repeated pulmonary artery long suture injection.
Front Cardiovasc Med. 2026;12:1736958.
Abstract

YUAN S, Hu X, Zhao Y, Dai H, et al
Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension.
Front Cardiovasc Med. 2026;12:1705102.
Abstract

DHAYYAT A, Stavem K, Jervan O, Hilde JM, et al
Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease.
Pulm Med. 2026;2026:4127338.
Abstract

KANAGARAJ UK, Kuan MTY, Castaldo M, Skarsgard E, et al
Liver herniation in congenital diaphragmatic hernia is associated with delayed resolution of pulmonary hypertension.
Pediatr Neonatol. 2026 Jan 22:S1875-9572(26)00004.
Abstract

LUI JK, Cozzolino M, Winburn M, Trojanowski MA, et al
Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain.
Rheumatology (Oxford). 2026 Jan 30:keag053. doi: 10.1093.
Abstract

SHAUKAT M, Grunig E, Haas S, Haas J, et al
Heritable pulmonary arterial hypertension: new genetic findings and environmental triggers.
Sci Rep. 2026;16:4121.
Abstract

WANG J, Wang Y, Shi R, Xu S, et al
Allicin ameliorates right heart dysfunction in rats suffering from pulmonary arterial hypertension by regulating Ca(2+) communication between the sarcoplasmic reticulum and mitochondria.
Biomed Pharmacother. 2026;195:119046.
Abstract

LI Z, Chen K, Wu W
Right atrial CCR2(+) macrophages mediate atrial fibrillation in rat with monocrotaline-induced pulmonary arterial hypertension.
Int Immunopharmacol. 2026;172:115920.
Abstract

CHEN Q, Jia N, Zhang X, Liu J, et al
Calycosin ameliorates high-altitude pulmonary edema by regulating macrophage polarization through the PPAR-gamma/NF-kappaB pathway: a comprehensive analysis of network pharmacology, molecular docking, and experimental validation.
J Ethnopharmacol. 2026;360:121200.
Abstract

DE MARCO T, Paoli CJ, Germack HD, Croteau NS, et al
Exploring the relationship between adherence and outcomes in pulmonary arterial hypertension: A retrospective cohort study in the United States.
Respir Med. 2026;252:108649.
Abstract

MA K, Zhu Y, Liu W, Zhu X, et al
CMR-based estimation of mean pulmonary arterial pressure and pulmonary vascular resistance in connective tissue disease-associated pulmonary arterial hypertension.
Clin Radiol. 2026;93:107199.
Abstract

WATTANARAT B, Foocharoen C, Panitchote A
Clinical predictors of mortality in critically ill systemic sclerosis patients: a 6-year retrospective cohort study.
Rheumatology (Oxford). 2026;65:keag008.
Abstract

WANG J, Jin J, Zhang M, Chen X, et al
Mesenchymal stromal cells alleviate pulmonary arterial hypertension by suppressing pulmonary arterial adventitial fibroblast activation and extracellular matrix remodeling via the SOCS3/STAT3 pathway.
Stem Cell Res Ther. 2026;17:67.
Abstract

ISHIDA N, Oishi H, Niikawa H, Suzuki T, et al
Bilateral lung transplantation with simultaneous aortic replacement using donor aorta in a patient with pulmonary arterial hypertension and patent ductus arteriosus.
J Cardiothorac Surg. 2026;21:64.
Abstract

QIAN W, Zhang Y, Dai J, Shan L, et al
TAPSE/PASP combined with IVC can identify poor prognosis in PAH patients with low and intermediate risk.
Clin Rheumatol. 2026;45:1215-1224.
Abstract

CACHEUX M, Strauss B, Parajuli S, Halouani A, et al
Extracellular-cAMP suppresses pulmonary arterial hypertension-induced ventricular arrhythmias.
J Mol Cell Cardiol. 2026;211:109-118.
Abstract

MELENDRES-GROVES LD, Channick RN, Chin KM, McLaughlin VV, et al
Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies.
Adv Ther. 2026;43:231-254.
Abstract

CLARKE M, Ataya A, Turkin AM, Parikh R, et al
Transitioning Between Treprostinil Formulations: Evidence and Strategies.
Adv Ther. 2026;43:20-48.
Abstract

SEPLOWE M, Isath A, Michaud L, Frishman WH, et al
Pulmonary Artery Hypertension: Fifty Years Following Pneumonectomy in Infancy.
Cardiol Rev. 2026;34:175-177.
Abstract

LIU JY, Chen J, Chen QY, Li HB, et al
Liquid-liquid phase separation of EphB4 drives pulmonary hypertension via YAP activation.
Cell Rep. 2026;45:116992.
Abstract

AMBARDAR Y, Wazib S, Afghan S, Iqbal Alam M, et al
Tribulus terrestris L. confers protection against hypoxia induced pulmonary hypertension via regulation of HIF/ NF-kappaB signalling pathway.
J Ayurveda Integr Med. 2026;17:101296.
Abstract

VON VISGER TT, Gill AS, Matura LA
Mindfulness knowledge and practice in patients with cardiopulmonary conditions: A qualitative thematic analysis of adults living with pulmonary hypertension and chronic obstructive pulmonary disease(?).
Heart Lung. 2026;78:102740.
Abstract

NAVARRO-LLINARES L, Garcia-Leon B, de la Bastida-Casero L, Oliver E, et al
The Vascular-Immune Cells Crosstalk and Microenvironment in Pulmonary Hypertension.
Compr Physiol. 2026;16:e70110.
Abstract

ZHOU J
Prevalence and risk factors of pulmonary hypertension in maintenance hemodialysis patients based on echocardiography.
Medicine (Baltimore). 2026;105:e43845.
Abstract

NAIDOO A
Survival in sight: Rethinking PDE5 inhibitors in ILD-associated pulmonary hypertension.
Afr J Thorac Crit Care Med. 2025;31:e2720.
Abstract

FU X, Lei C, Xu A, Yuan L, et al
Combined Effects of Pulmonary Hypertension and Heart Valve Calcification on Cardiovascular Outcomes in Maintenance Hemodialysis Patients: A Risk Stratification Study Using Echocardiography.
Kidney Dis (Basel). 2025;12:129-139.
Abstract

LUCA AC, Rosu ST, Diaconescu C, Mindru DE, et al
The First 1000 Days: Maternal Nutrient Intake-A Window of Opportunity for Pulmonary Hypertension-A Narrative Review.
Nutrients. 2026;18:424.
Abstract

HIRONO K, Uchida K, Ishii T, Ishida H, et al
Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries.
J Clin Med. 2026;15:1087.
Abstract

LIU YS, Lin YC, Tsai SC, Wang HY, et al
Diagnostic Performance of Quantitative Lung Perfusion SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study.
Diagnostics (Basel). 2026;16:413.
Abstract

ZHU Y, Cui L, Zhou T, Xu H, et al
The quality and reliability of short videos about pulmonary hypertension on Bilibili and TikTok: a cross-sectional study.
BMC Cardiovasc Disord. 2026 Feb 12. doi: 10.1186/s12872-026-05597.
Abstract

ZHANG Y, Dai Q, Gong L, Zheng R, et al
Integrative Machine Learning and Experimental Validation Identify FIS1 as a Candidate Biomarker Linked to Mitochondrial Dynamics in Pulmonary Hypertension.
Cells. 2026;15:301.
Abstract

REGUERA JV, Ortega PP, San Martin Bragado M, Belloch MC, et al
Extracorporeal Cardiopulmonary Resuscitation due to Left Atrial Myxoma With Severe Pulmonary Hypertension: A Challenging Combination.
JACC Case Rep. 2026 Feb 12:106957. doi: 10.1016/j.jaccas.2026.106957.
Abstract

TAGER D, Collier P, Akintoye EO, Wang Y, et al
Echocardiographic Assessment After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Which Parameters Reflect Improved Right Ventricular Function?
Pulm Circ. 2026;16:e70261.
Abstract

CAI D, Zhou R, Fujise K, Chen SY, et al
Murine Aortopulmonary Shunt Model of Flow-Driven Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2026 Feb 12:10.1161/ATVBAHA.125.323657.
Abstract

LI L, Huang X, Cheng M, He C, et al
Pulmonary hypertension: etiology and anti-inflammatory treatment pathways of natural products.
Front Pharmacol. 2026;16:1743782.
Abstract

WEI H, Guo S, Ding W, Yang Y, et al
Altered gut microbial dynamics and the antivascular remodeling effect of carnosine in hypobaric hypoxic pulmonary hypertension rats.
Acta Biochim Biophys Sin (Shanghai). 2026 Feb 10. doi: 10.3724/abbs.2025237.
Abstract

THAKUR A, Thakur A, Bhatia K
Letter to the Editor: Pulmonary Hypertension as a Determinant of In-Hospital Mortality in COPD: Insights and Methodological Considerations.
COPD. 2026;23:2621733.
Abstract

DING S, Chen J, Li Z, Yu Y, et al
Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets.
Cell Prolif. 2026 Feb 10:e70179. doi: 10.1111/cpr.70179.
Abstract

PAGNONI G, Vicenzi A, Coppi F
Right Atrial Function and Tricuspid Regurgitation in Chronic Thromboembolic Pulmonary Hypertension.
Echocardiography. 2026;43:e70406.
Abstract

BARSAIN M, Parveen R, Devi K, Tomar MS, et al
Improving mitochondrial health by pyrroloquinoline quinone (PQQ) prevents ultrafine carbon particle (UFCP) induced emphysema and associated pulmonary hypertension.
Free Radic Biol Med. 2026;247:267-285.
Abstract

LI XM, Yang L, Yang ZG
Taussig-Bing heart with pulmonary hypertension in a rare adult survivor: multimodality imaging insights.
Eur Heart J. 2026 Feb 9:ehag026. doi: 10.1093.
Abstract

WANG M, Song J, Yu Y, Chen R, et al
An applied study on the assessment of concomitant pulmonary hypertension in patients with chronic obstructive pulmonary disease based on whole-lung CT imaging histologic features.
J Thorac Dis. 2026;18:18.
Abstract

ZHANG X, Yang J, Yang Z, Liu T, et al
Current Evidence on the Potential Role of Endothelial SHP-1 in Pulmonary Vascular Remodeling Associated With Pulmonary Hypertension.
Rev Cardiovasc Med. 2026;27:39059.
Abstract

DENG X, Yuan T, Qian J, Wang Q, et al
Rare TRAF5 coding variants in systemic lupus erythematosus patients aggravate pulmonary hypertension via endothelial dysfunction.
Innovation (Camb). 2025;7:101111.
Abstract

ALESSANDRA G, Beatrice M, Sara C, Roberta M, et al
Preselected and preferred immersive virtual reality versus narrative alone to induce post-stress relaxation in patients with pulmonary arterial hypertension: A pilot study on perceived stress and heart rate.
Br J Health Psychol. 2026;31:e70059.
Abstract

CINAR C, Yildizeli SO, Atas H, Balcan B, et al
Obstructive sleep apnea and echocardiographic indicators of elevated pulmonary hypertension probability after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
Sleep Med. 2026;141:108827.
Abstract

GENTLE SJ, Hebert A
Beyond the Echocardiogram: Cardiac Catheterization in Infants With Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
J Pediatr. 2026 Feb 5:115026. doi: 10.1016/j.jpeds.2026.115026.
Abstract

LEUILLIER M, Chelgham M, Messaoudi H, Tu L, et al
Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension.
Compr Physiol. 2026;16:e70108.
Abstract

CHANG WT, Shih JY, Lin CH, Hsu CH, et al
Exosomal miR-21 mitigates pulmonary hypertension-induced right-heart remodeling by preserves mitochondrial homeostasis.
J Transl Med. 2026 Feb 6. doi: 10.1186/s12967-026-07795.
Abstract

ZHANG C, Huang T, Guo X, Fan Y, et al
Hemoglobin adduction and impaired oxygen transport define the etiology of pyrrolizidine alkaloid-induced pulmonary arterial hypertension.
Phytomedicine. 2026;152:157847.
Abstract

YIN Q, Xiong Z, Wang X, Wei TW, et al
Paeonol alleviates pulmonary arterial hypertension by activation of BRCC3.
Phytomedicine. 2026;152:157888.
Abstract

CHE H, Yi J, Li J, Hu Y, et al
Unveiling the protective mechanisms of Pipa Qingfei Decoction in pulmonary arterial hypertension: Insights from network pharmacology, metabolomics and Mendelian randomization.
J Ethnopharmacol. 2026;361:121287.
Abstract

DE ARAUJO ALVES CC, Santos RS, Rocha NN, Felix NS, et al
Targeting pulmonary arterial hypertension with aerobic training: anti-inflammatory and cardioprotective effects enhance survival in experimental models.
J Appl Physiol (1985). 2026;140:577-588.
Abstract

ZHOU J, Yang Y, Zou H, Jiang X, et al
A carrier-free nanomedicine targeting vascular remodeling and oxidative stress for enhanced pulmonary arterial hypertension therapy.
J Colloid Interface Sci. 2026;708:139821.
Abstract

CETIN GUVENC R, Guvenc TS, Karakaya ES, Acik H, et al
Abnormal Right Ventricular to Pulmonary Artery Coupling in Patients with End-Stage Kidney Disease and Normalization After Renal Transplantation: An Observational Study.
Nephron. 2025 Oct 30:1-18. doi: 10.1159/000549077.
Abstract

AUSTIN ED, Mullen MP, Avitabile CM, Krishnan US, et al
Pulmonary Hemodynamics and Long-Term Outcomes in Children with Pulmonary Hypertension-Associated Bronchopulmonary Dysplasia.
J Pediatr. 2026;289:114869.
Abstract

GENSKE F, Rawish E, Macherey-Meyer S, Buchel C, et al
Comparison of different venous access ways for right heart catheterization-a meta-analysis.
Hellenic J Cardiol. 2026;87:121-132.
Abstract

GUDER G, Reiter T, Fette G, Hundertmark M, et al
Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines.
Clin Res Cardiol. 2026;115:395-404.
Abstract

PASQUINUCCI M, Bonsembiante L, Mezzalira S, Locallo M, et al
A Rare Case of Reversible Pulmonary Hypertension Phenotype in a Child with Scurvy: Aetiologies Insights.
Reports (MDPI). 2026;9:44.
Abstract

ALRASHEDI S, Alharbi L, Alotaibi M, Alzahrani I, et al
Evaluating the Impact of Inspiratory Muscle Training on Respiratory Function and Exercise Capacity in Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Adv Respir Med. 2026;94:13.
Abstract

SCELSI L, Badagliacca R, D'Alto M, Acquaro M, et al
Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up.
ESC Heart Fail. 2026;13:xvaf012.
Abstract

MELIN M, Lofman IH, Matan D, Nygren M, et al
Agreement of thermodilution and direct Fick methods for cardiac output across varying haemodynamic conditions.
ESC Heart Fail. 2026;13:xvaf001.
Abstract

MILES KG, Dorobantu DM, Douwes JM, Frank BS, et al
Current State of RV Multimodality Imaging in Pediatric Pulmonary Hypertension: Current Evidence, Knowledge Gaps, and Future Research Directions.
Circ Cardiovasc Imaging. 2026 Feb 19:e019264.
Abstract

HOWARD LS, Kiely DG, Lawrie A, Maron BA, et al
Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.
Pulm Circ. 2026;16:e70258.
Abstract

VILLA A, Sanges S, Sobanski V, Lamblin N, et al
Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.
Eur Respir Rev. 2026;35:250137.
Abstract

LI H, Li M, Qiu C, Yang Y, et al
Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation.
Clin Exp Hypertens. 2026;48:2629926.
Abstract

MOHAMED-ALI N, Acquaah V, Al-Jaber M, Bhatt R, et al
Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort.
Front Immunol. 2026;17:1755076.
Abstract

RIOU M, Beurnier A, Montani D
Pulmonary hypertension associated with COPD: exploring the complex spectrum of an unmet clinical challenge.
ERJ Open Res. 2026;12:01153-2025.
Abstract

TSANG KD, Caudri D, Zaat C, Tramper-Stranders GA, et al
Peri and Neonatal Risk Factors and Structural Lung Abnormalities Predict Hypoxic Challenge Test Failure in Infants With Severe Bronchopulmonary Dysplasia.
Pediatr Pulmonol. 2026;61:e71517.
Abstract

ALOWAMI M, Ch'ng BX, Babasola RO, Tan CH, et al
Efficacy and Safety of Selexipag in Pulmonary Hypertension: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Cardiol Rev. 2026 Feb 18. doi: 10.1097/CRD.0000000000001185.
Abstract

YAMAMOTO S, Sakamaki F
Current perspectives on imaging modalities in the diagnosis and management of pulmonary hypertension.
Respir Investig. 2026;64:101389.
Abstract

CHENG K, Zheng T, Guo L, Guo M, et al
GLI1 Promotes Hypoxia Induced Pyroptosis of PASMCs and Aggravates Pulmonary Arterial Hypertension in Rats by Upregulating HDAC1 Expression.
Cardiovasc Toxicol. 2026;26:28.
Abstract

WANG B, Zhang Z, Chen K, Qin Y, et al
Fatal pulmonary artery dissection in the setting of aneurysm and pulmonary hypertension: a case report and literature review.
J Cardiothorac Surg. 2026 Feb 16. doi: 10.1186/s13019-026-03880.
Abstract

MANCA P, Puglisi S, Pascalis L, Nuzzi V, et al
Prognostic Role of Invasively Determined Pulmonary Hypertension in Ambulatory Patients with Advanced Heart Failure: A Prospective Cohort Study.
Curr Probl Cardiol. 2026 Feb 14:103301. doi: 10.1016/j.cpcardiol.2026.103301.
Abstract

BHADRA OD, Weimann J, Waldschmidt L, Demal TJ, et al
Long-term outcome of patients with severe pulmonary hypertension undergoing transcatheter aortic valve implantation.
Front Cardiovasc Med. 2026;12:1678025.
Abstract

PHU QUY H, Doan Duc D, Nguyen Duc T
A diagnostic challenge: unveiling chronic thromboembolic pulmonary hypertension in the absence of visible thrombi: a case report.
Eur Heart J Case Rep. 2026;10:ytag034.
Abstract

NICOL C, Kristrom K, Bettembourg V
Case Report: Anaesthetic management in a canine patient with severe atrioventricular septal defect and pulmonary hypertension undergoing non-cardiac surgery.
Front Vet Sci. 2026;13:1736215.
Abstract

GUPFERT M, Weber L, Haager PK, Baier P, et al
Impact of Right Heart Catheterization and the 2022 ESC/ERS Definition of Pulmonary Hypertension in Patients With Mitral Regurgitation Undergoing Valve Repair/Replacement.
Pulm Circ. 2026;16:e70265.
Abstract

KUME H, Nosaka N, Yasumura R
Venoarterial Extracorporeal Membrane Oxygenation Rescue for Catastrophic Grade 3 Bone Cement Implantation Syndrome in a Patient With Aortic Valve Stenosis and Moderate Pulmonary Hypertension: A Case Report.
Cureus. 2026;18:e101514.
Abstract

QUE W, Li S, Li J, Li Y, et al
The effect of atorvastatin combined with azithromycin on lung function and right heart function in COPD patients with concomitant pulmonary hypertension.
Front Med (Lausanne). 2026;12:1667773.
Abstract

SIUBA MT, Lane J, Mendpara V, Toth D, et al
Cardiac Output During Exercise: Thermodilution Versus Direct Fick.
J Am Heart Assoc. 2026;15:e047657.
Abstract

QI Y, Dong Q, Luo P, Meng J, et al
USP15 promotes proliferation, migration, and apoptosis resistance of pulmonary arterial smooth muscle cells by targeting MDM2.
Arch Biochem Biophys. 2026;778:110733.
Abstract

HABIB NG, Adhia A, Lopez D, Sandros M, et al
Selection of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension: A Comprehensive Narrative Review.
Adv Ther. 2026;43:468-519.
Abstract

NOH CY, Danzer E, Bhombal S, Chock VY, et al
Early postnatal echocardiographic characteristics impact survival and extracorporeal life support in congenital diaphragmatic hernia.
Pediatr Res. 2025 Oct 1. doi: 10.1038/s41390-025-04443.
Abstract

JENKINSON A, Harris C, Bafadhel M, Razavi R, et al
Longitudinal changes in cardiopulmonary outcomes of adults born extremely prematurely: United Kingdom Oscillation Study.
Pediatr Res. 2025 Jun 16. doi: 10.1038/s41390-025-04190.
Abstract

CHEN Q, Lin L, Xiong S, Ge D, et al
Risk factors for severe pertussis in children and the application of exchange transfusion.
Pediatr Res. 2026;99:248-253.
Abstract

LYU Y, Nagra R, DeLonais-Parker AR, Lentine KL, et al
Association of pre-transplant pulmonary hypertension and post-transplant major adverse cardiovascular events in kidney transplant recipients: a retrospective study.
BMC Nephrol. 2026 Feb 27. doi: 10.1186/s12882-026-04832.
Abstract

LAI Y, He L, Cai H, Zhou W, et al
Feasibility and safety of right heart catheterization via median cubital vein in patients with pulmonary hypertension.
BMC Cardiovasc Disord. 2026 Feb 27. doi: 10.1186/s12872-026-05604.
Abstract

KIELY DG, Wort SJ, Funes D, Fernandez Delgado M, et al
Incidence and prevalence of pulmonary hypertension in chronic lung disease: insights from a retrospective cohort study using a UK nationwide health database.
BMJ Open. 2026;16:e108228.
Abstract

TOSUN D, Bingol I, Akcay N
Lamp Oil Poisoning: Pulmonary Hypertension Following Oil Aspiration Successfully Treated with Inhaled Nitric Oxide.
Klin Padiatr. 2026 Feb 27. doi: 10.1055/a-2814-3185.
Abstract

J WHITLEY WN, Millis RM
Epigenetic Drivers of Pulmonary Hypertension: Environment Meets Genome.
Cureus. 2026;18:e104241.
Abstract

TORRES YP, Aristizabal-Pachon AF, Otero L
TRPC Channels as Mediators of Hypoxia-Induced Pulmonary Hypertension in Obstructive Sleep Apnea.
Int J Mol Sci. 2026;27:1861.
Abstract

BESTE NC, Bunck AC, Kottlors J, Reimer RPWM, et al
Pulmonary Artery and Vein Morphology as an Imaging Biomarker for the Diagnosis of Pulmonary Hypertension.
Diagnostics (Basel). 2026;16:619.
Abstract

SINGH Y, Nath S, Gahlaut S, Chan B, et al
Physiology-Based Diagnosis and Management of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension (BPD-PH).
Children (Basel). 2026;13:272.
Abstract

PERRET PL, Kim JH, Winkler A, Ott C, et al
Dysregulated Klotho and FGF23 signaling aggravates vascular remodeling in age-related pulmonary hypertension.
Cardiovasc Res. 2026 Feb 27:cvag048. doi: 10.1093.
Abstract

TREES C
Evidence-Based Management of Persistent Pulmonary Hypertension.
Neonatal Netw. 2026;45:9-17.
Abstract

SCHMERMUND BN, Rieth AJ, Rademann M, Wilke PC, et al
Manual long axis strain compared to automated feature-tracking deformation imaging for identification of masked left heart involvement in pulmonary hypertension.
Int J Cardiovasc Imaging. 2026 Feb 26. doi: 10.1007/s10554-026-03664.
Abstract

HU C, Chen Z, Lv L, Zhu Y, et al
Clinical Application of Inhaled Nitric Oxide in Conditions of Excessive Right Heart Load: A Review from Neonatal Pulmonary Hypertension to Perioperative Cardiac Surgery Management.
J Cardiovasc Dev Dis. 2026;13:81.
Abstract

IMTIAZ H, Mohammed AS, Mondal A, Kodali LSM, et al
Predictors of Secondary Pulmonary Hypertension-Related Hospitalizations and Subsequent Mortality in Adults with Obstructive Sleep Apnea.
Diseases. 2026;14:73.
Abstract

KIRIS A, Zhang P, Bronk P, Prins KW, et al
Supraventricular Arrhythmias in Pulmonary Hypertension: A Comprehensive Review From Preclinical Evidence to Clinical Practice.
Pulm Circ. 2026;16:e70268.
Abstract

TONG W, Cheng R, Chen X, Zhang X, et al
Tea consumption is associated with a reduced risk of high-altitude pulmonary hypertension among high-altitude permanent inhabitants in the Tibetan population: a case-control study.
Front Nutr. 2026;13:1732242.
Abstract

CHANG WT, Garcia-Guasch L, Chan IP, Montoya-Alonso JA, et al
Development and evaluation of a composite echocardiographic score for predicting pulmonary hypertension severity in dogs.
J Vet Intern Med. 2026;40:aalag004.
Abstract

PARIKH T, Khan SA, Rao A, Patel B, et al
Response to "Pulmonary Hypertension as a Determinant of In-Hospital Mortality in COPD: Insights and Methodological Considerations".
COPD. 2026;23:2631253.
Abstract

ZEDER K, Maron BA
Social networks are not just for friends: Untangling care patterns in pulmonary hypertension.
Ann Am Thorac Soc. 2026 Feb 25:aaoag003. doi: 10.1093.
Abstract

XIE F, Feng J, Li K, Chen Y, et al
Targeting Pulmonary Hypertension: Elucidating Sophocarpine's Protective Role via Preclinical Models.
Mediators Inflamm. 2026;2026:5524066.
Abstract

LI W, Zheng Y, Fan M, Sun Y, et al
Pulmonary rehabilitation for pulmonary hypertension in high-altitude areas: a mixed-methods study of medical staff's perspectives.
Front Public Health. 2026;14:1740477.
Abstract

BAYBUTT RC, Smith VB, Kearns DG, Stafford SB, et al
Monocrotaline toxicity in rats: decreased lung retinol and elevated alpha-tocopherol levels in lung and liver.
J Nutr Sci. 2026;15:e16.
Abstract

BRIDI GDP, Freire da Silva B, Sobral-Alves JB, Carvalho CRF, et al
Mechanisms of exercise limitation and prevalence of pulmonary hypertension in hypersensitivity pneumonitis.
ERJ Open Res. 2026;12:00656-2025.
Abstract

YATA M, DeFrancesco TC, Bonagura JD, Papich MG, et al
Population Pharmacokinetics of Sildenafil in Dogs With Naturally Occurring Pulmonary Hypertension.
J Vet Pharmacol Ther. 2026 Feb 24. doi: 10.1111/jvp.70057.
Abstract

LTEIF C, Wachs P, Sharma RK, Duarte JD, et al
The role of Id genes on pulmonary hypertension development in left heart failure.
Am Heart J Plus. 2025;61:100692.
Abstract

WANG K, Fan J, Mei L
The risk factors associated with pulmonary hypertension in patients with left heart diseases.
Medicine (Baltimore). 2026;105:e47799.
Abstract

PORTES AMO, de Moura AG, de Jesus Silva F, Guimaraes-Ervilha LO, et al
Previous resistance exercise training mitigates progression of right ventricle dysfunction and remodeling in male rats with pulmonary arterial hypertension.
Physiol Rep. 2026;14:e70786.
Abstract

MOGHADAS Z, Eftekhar SP, Pourkia R, Saravi M, et al
Pulmonary hypertension in beta thalassemia: a prospective cohort study on treatment outcomes and cardiopulmonary function.
Acta Cardiol. 2026 Feb 23:1-6. doi: 10.1080/00015385.2025.2593662.
Abstract

ISHIKAWA K, Nakao H, Shinjo D, Kubota M, et al
Trisomy 13 as a risk factor for pulmonary hypertension induced by diazoxide.
Ann Pediatr Cardiol. 2025;18:351-356.
Abstract

EID HA, Hamdy RM, Eldosoky MA, Elhamed SSA, et al
Unveiling MicroRNA-21 as a non-invasive diagnostic biomarker in chronic obstructive pulmonary disease-associated pulmonary hypertension: Comparative insights with NT-proBNP.
Lung India. 2026;43:178-184.
Abstract

LI Z, Li H, Qiao W, Yu S, et al
Multi-omics dissection of high TWAS-active endothelial pathogenesis in pulmonary arterial hypertension: bridging single-cell heterogeneity, machine learning-driven biomarkers, and developmental reprogramming.
Int J Surg. 2026;112:2650-2667.
Abstract

KOZLOWSKA WU, Lomzik J, Kaminski K, Kazimierczyk R, et al
Matrix metalloproteinases and tissue inhibitors of metalloproteinases as potential biomarkers for pulmonary arterial hypertension: A review.
Adv Clin Exp Med. 2026;35:361-376.
Abstract

BATHEJA V, Modasia B, Puri S, Meshram HS, et al
Dual carrier status for HUPRA (hyperuricemia, pulmonary hypertension, renal failure, and alkalosis) syndrome and Wilson disease in a young dialysis patient: clinical and genetic counseling implications.
Clin Transplant Res. 2026 Mar 5. doi: 10.4285/ctr.25.0071.
Abstract

LIANG Q, Wang Y, Zhang X, Guo D, et al
Acox1 induces lipid peroxidation and metabolic shifting to promote PASMCs proliferation in hypoxia-induced pulmonary hypertension.
Free Radic Biol Med. 2026;248:469-484.
Abstract

MANSO TEJERINA P, Loaiza Q, Andres C, Margallo Iribarnegaray J, et al
Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary Hypertension.
Clin Transplant. 2026;40:e70493.
Abstract

LIU S, Yuan H, Cao J, Cai L, et al
Circulating fatty acid profiles and risk of pulmonary arterial hypertension: Evidence from a large prospective cohort study.
Medicine (Baltimore). 2026;105:e47645.
Abstract

ONOFRE MESF, Santos RT, Rocha NN, Caldeira DAF, et al
Mitochondrial Transplantation from Bone Marrow Mesenchymal Stromal Cells Combined with Sildenafil Attenuated Vascular Remodeling and Improved Right Ventricular Dysfunction in Experimental Pulmonary Arterial Hypertension.
Int J Mol Sci. 2026;27:1761.
Abstract

LIN Y, Wang A, Valdez-Jasso D
Adventitial Fibrosis and Fibroblast Mechanosensitivity Are Shaped by Sex and Hormonal Status in Pulmonary Arterial Hypertension.
Cells. 2026;15:354.
Abstract

JIANG R, Li L, Luo Y, Wang W, et al
GM-CSF exacerbates pulmonary arterial hypertension via CCL2/CCR2-axis-mediated macrophage NLRP3 inflammasome activation.
Int Immunopharmacol. 2026;174:116394.
Abstract

SUZUKAWA A, Hemmi R, Fujiwara M, Motomura T, et al
Repositioning lidocaine as a TMEM16A Ca(2+)-activated Cl(-) channel blocker for the treatment of pulmonary arterial hypertension.
J Pharmacol Exp Ther. 2026;393:103799.
Abstract

VERMA S, Seltzer BHS, Fisher JC, Cicalese E, et al
Outcomes in early term neonates requiring extracorporeal membrane oxygenation.
J Perinat Med. 2025 Oct 20. doi: 10.1515/jpm-2025-0235.
Abstract

YANG MM, Liu S, Wax M 2nd, Lee S, et al
Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis.
Arthritis Rheumatol. 2026;78:428-437.
Abstract

TORUN EG, Ozdemiroglu N, Bagrul D, Ece I, et al
Pulmonary Artery Pulsatility Index: A Novel Marker for Risk Assessment and Prognosis in Pediatric Idiopathic Pulmonary Arterial Hypertension.
Pediatr Cardiol. 2026;47:1788-1797.
Abstract

RODRIGUEZ OGANDO A, Sabate-Rotes A, Moya Bonora A, Albert de la Torre L, et al
Macitentan in Children with Pulmonary Arterial Hypertension: A Multicenter Experience.
Pediatr Cardiol. 2026;47:1572-1580.
Abstract

RUESS A, Stadler S, Stark T, Berezucki E, et al
Hemodynamic effects of cycle ergometry and low-intensity handgrip in patients with pulmonary hypertension.
Front Med (Lausanne). 2026;13:1727173.
Abstract

GIANNAKOULAS G, Preston IR, Gatzoulis MA
Advancing the science and care of pulmonary hypertension, globally.
Int J Cardiol Congenit Heart Dis. 2025;23:100651.
Abstract

YU Y, Wang Y, Yang Z, Li Z, et al
Corrigendum to "Methyleugenol alleviates pulmonary vascular remodeling in rats with high-altitude pulmonary hypertension by improving pulmonary smooth muscle cell function" [Biomed. Pharmacother. 187 (2025) 118109].
Biomed Pharmacother. 2026 Mar 11:119202. doi: 10.1016/j.biopha.2026.119202.
Abstract

CHEN J, Zhang ZL, Chen YY, Ren JH, et al
[Use of modified balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension: a retrospective study from a single center].
Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:317-323.
Abstract

HUANG Q, Xiong CM, Wang JZ, Zhai ZG, et al
[Enhancing the capacity of pulmonary vascular intervention system in China: current status, opportunities, and challenges].
Zhonghua Jie He He Hu Xi Za Zhi. 2026;49:251-256.
Abstract

YOSHIDA K, Hosokawa K, Hiraide T, Akagi S, et al
Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension a
BMJ Open. 2026;16:e113430.
Abstract

ZHAO J, Li N, Shi S, Zhao Y, et al
Chronic thromboembolic pulmonary hypertension: insights from the 100 most cited papers: a bibliometric perspective.
J Thorac Dis. 2026;18:98.
Abstract

WANG WT, Li X, Wang T, Ferrizzi SA, et al
Pulmonary Vascular Signaling in Pulmonary Hypertension: Potential Role of Endothelial Ca(2+) Signaling in Cellular Senescence and Inflammasome Activation.
Arterioscler Thromb Vasc Biol. 2026 Mar 12. doi: 10.1161/ATVBAHA.125.322489.
Abstract

ZHENG RX, Wang SZ, Tan JL, Cao XY, et al
[Junren Bufei Yixin Granules attenuates hypoxic pulmonary hypertension via PTBP1/PKM2 signaling pathway].
Zhongguo Zhong Yao Za Zhi. 2026;51:543-552.
Abstract

TONG XL, Zhang L, Zhu J, Tong JB, et al
[Mechanisms of Qibai Pingfei Capsules in inhibiting pyroptosis of pulmonaryartery adventitial fibroblasts via regulating NLRP3/Caspase-1/ GSDMD pathway to intervene in COPD complicated by pulmonary arterial hypertension].
Zhongguo Zhong Yao Za Zhi. 2025;50:6892-6900.
Abstract

JUTANT EM, Humbert M, Montani D, Khoury J, et al
Pulmonary hypertension associated with nonparenchymal restrictive lung diseases.
Eur Respir Rev. 2026;35:250187.
Abstract

PANG L, Du S, Wu S, Xian Q, et al
Genetic assessment of the causal relationship between obstructive sleep apnea and pulmonary hypertension: Mendelian randomization and meta-analysis.
Respir Med. 2026;255:108760.
Abstract

LI L, Liu B, Zhang M, Wang D, et al
TG2 (transglutaminase 2) promotes PINK1/Parkin-dependent mitophagy in pulmonary hypertension by regulating the TRPC6.
Free Radic Biol Med. 2026 Mar 9:S0891-5849(26)00180.
Abstract

JING H, Liu J, Guo Y, Gao Z, et al
Smooth Muscle NR4A3 Upregulation Caused by Endothelial Caveolin-1 Deficiency Mediates Vascular Remodeling and Pulmonary Hypertension.
Free Radic Biol Med. 2026 Mar 9:S0891-5849(26)00188.
Abstract

YANG MX, Wu ZZ, Wu DW, Chen MH, et al
Role of PKM2 Tetramer in Modulating Endothelial Mitochondrial Dysfunction in a Rat Model of Chronic Thromboembolic Pulmonary Hypertension.
Physiol Res. 2026;75:45-53.
Abstract

ZEIDAN EM, Nagarajan SA, Sydykov A, Bier J, et al
The effect of mitoTEMPO on the development of hypoxia-induced pulmonary hypertension in male mice.
Physiol Rep. 2026;14:e70804.
Abstract

HERTIG D, Furian M, Muller J, Mayer L, et al
Effect of short-term supplemental oxygen therapy on 6-min walk distance in highlanders at risk for pulmonary hypertension: a randomised, crossover trial.
ERJ Open Res. 2026;12:00724-2025.
Abstract

KEKEC L, Radisavljevic Vitas S, Bervar M, Taleska Stupica G, et al
Perioperative Use of Pulmonary Artery Catheter in a Patient With Severe Chronic Thromboembolic Pulmonary Hypertension Undergoing Major Gynecological Surgery: A Case Report.
Cureus. 2026;18:e103094.
Abstract

HIROSE M, Nakano Y, Adachi S, Sugiyama T, et al
Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.
Circ Rep. 2025;8:486-494.
Abstract

ZISMAN D, Sahay S, Bandyopadhyay D, Al-Astal A, et al
Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER Study.
Adv Ther. 2026 Mar 10. doi: 10.1007/s12325-026-03508.
Abstract

ZHAO Q, Su S, Chen J, Huayu M, et al
Kaempferol alleviates right ventricular hypertrophy in high-altitude pulmonary hypertension rats by modulating the AMPK/ACC/CPT1B axis and the AMPK-mediated LDHA/PDHA1 pathway.
Food Funct. 2026 Mar 10. doi: 10.1039/d5fo04265.
Abstract

KHILZI K, Blanco I, Piccari L, Barbera JA, et al
Smoking exposure on diagnosis and survival of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from REHAP registry.
Pulmonology. 2026;32:2640669.
Abstract

LACHANT D, Agarwal N, Norton K, Haight D, et al
Longitudinal Remote 6-Minute Walk Distance and Cardiac Effort Using Wearable Sensors in Pulmonary Hypertension.
Pulm Circ. 2026;16:e70278.
Abstract

TARRAS ES, Murayama A, Singh I, Freeman LM, et al
Industry Payments and Prescribing Patterns of Pulmonary Hypertension Therapies in the United States.
Pulm Circ. 2026;16:e70279.
Abstract

CHENG Q, Yang F, Wu C, Xiao D, et al
Machine learning-based predictive model for the diagnosis of PH pulmonary hypertension diagnosis integrating cardiac magnetic resonance imaging and clinical biomarkers.
BMC Med Imaging. 2026 Mar 9. doi: 10.1186/s12880-026-02254.
Abstract

MULAWARMAN R, Ongko Joyo E, Aefiansyah Putra MA, Agita Sembiring A, et al
Reversing the irreversible? A case of successful surgical repair in a late-presenting aortopulmonary window with severe pulmonary hypertension.
Egypt Heart J. 2026;78:15.
Abstract

SUBRAMANIAM J, Jonnakuti V, Collum SD, Martineau S, et al
Alternative Polyadenylation Signatures Distinguish Maladaptive Right Ventricular Remodeling in Pulmonary Hypertension: Implications for RNA-Based Diagnostics and Therapeutics.
Br J Biomed Sci. 2026;83:15687.
Abstract

CENDALI FI, Lisk C, Argabright A, Dzieciatkowska M, et al
Iron, arginine, and redox metabolism in peripheral blood mononuclear cells distinguishes sickle cell disease and pulmonary hypertension.
Hemasphere. 2026;10:e70318.
Abstract

QIN X, Zheng L, Zhao H, Li Q, et al
Identification of circulating microRNA biomarkers in pulmonary hypertension of group 2 for early detection.
Front Cardiovasc Med. 2026;13:1704427.
Abstract

MOUSTAFA M, Gopal H, Minnock C, Gaine S, et al
Rectus sheath block a retrospective review of a novel adjunct for treatment of the injection site pain associated with treprostinil subcutaneous infusion in pulmonary hypertension case series.
Pain Manag. 2026 Mar 9:1-7. doi: 10.1080/17581869.2026.2641557.
Abstract

FUJIWARA M, Yamamura A, Kondo R, Suzuki Y, et al
Therapeutic effects of fingolimod through sphingosine-1-phosphate signaling in pulmonary arterial hypertension.
J Pharmacol Sci. 2026;160:191-198.
Abstract

LI X, Mao Z, Wang C, Liu Y, et al
Intervention effect of small extracellular vesicles derived from dental pulp stem cells on a high-altitude pulmonary edema model in male rats.
Physiol Rep. 2026;14:e70810.
Abstract

KEMPTON H, Olsen N, Kearney K, Hayward CS, et al
The resistance-compliance relationship at low pulmonary resistance: Integrating pulmonary wedge pressure into right ventricular load assessment.
Physiol Rep. 2026;14:e70811.
Abstract

CUI H, Min F, Deng H, Wang Y, et al
Leonurine ameliorates hypoxic pulmonary hypertension by inhibiting cross-talk between neutropHils and endothelial cells via SERPINB3 targeting.
Int Immunopharmacol. 2026;176:116467.
Abstract

WANG Y, Shen R, Liu Y
Impact of pulmonary-artery-to-aorta ratio on clinical outcomes in patients undergoing transcatheter aortic valve implantation: A retrospective study.
Sci Prog. 2026;109:368504261431852.
Abstract

CHEN R, Liu C, Han J, Dong J, et al
Paradigm shift: from pulmonary vasodilation to cardiopulmonary dual-track therapy-a comprehensive review of pathophysiology and advances in pulmonary hypertension-associated right heart failure.
Respir Res. 2026 Mar 7. doi: 10.1186/s12931-026-03594.
Abstract

CAO Z, Ma W, Liu C
Hyperuricemia and Hypoxic Pulmonary Hypertension: Pathogenic Links, Clinical Evidence, and Emerging Therapeutic Insights.
Cardiovasc Drugs Ther. 2026 Mar 6. doi: 10.1007/s10557-026-07859.
Abstract

OGUNTADE AS, Ogah OS, Adebiyi AA, Oladokun B, et al
Right ventricular function, pulmonary hypertension and incident mortality in heart failure: Insights from a West-African cohort.
Cardiovasc J Afr. 2025;36:309-322.
Abstract

KARACA BAYSAL P, Urkut N, Girgin Dinc E, Gurcu ME, et al
Emergency cesarean section in pregnant women with severe pulmonary hypertension: the potential role of extracorporeal life support.
Ulus Travma Acil Cerrahi Derg. 2026;32:177-183.
Abstract

SUZUKI Y, Ramadhiani R, Ryanto GRT, Musthafa A, et al
Loss of Endothelin-2 in Pulmonary Neuroendocrine Cells Promotes the Development of Hypoxia-induced Pulmonary Hypertension.
Clin Sci (Lond). 2026 Mar 3:CS20250135. doi: 10.1042/CS20250135.
Abstract

NOGUCHI Y, Miyake M, Mima H, Matsutani H, et al
Usefulness of exercise stress echocardiography to identify masked pulmonary hypertension associated with hyperthyroidism.
J Cardiol Cases. 2025;33:75-77.
Abstract

WANG R, Tan J, Li G, Pan Z, et al
Development and internal validation of a machine learning-based prediction model for pulmonary hypertension in COPD.
Front Med (Lausanne). 2026;13:1752113.
Abstract

MUNOZ-BONET JI, Sebastian-Cuevas FJ, Flor-Macian EM, Ortega-Sanchez MDC, et al
Hypercapnia as a Key Mechanism in the Development of Pulmonary Hypertension in Malignant Pertussis: A Case Report.
Respirol Case Rep. 2026;14:e70528.
Abstract

ANDRYAN DP, Hasanah DY, Atmadikoesoemah CA
The potential effect of calcium sensitizer in pulmonary hypertension post-coronavirus disease-19 infection in presumptive familial dilated cardiomyopathy: a case report.
J Med Case Rep. 2026 Mar 5. doi: 10.1186/s13256-026-05854.
Abstract

KHALIL F, Asleh R, Mawer S, Kim K, et al
Interplay of Pulmonary Hypertension and the Effects of Panel-Reactive Antibodies on Outcomes of Heart Transplant Recipients Bridged With Left Ventricular Assist Device.
J Am Heart Assoc. 2026 Mar 4:e044572. doi: 10.1161/JAHA.125.044572.
Abstract

BUNCLARK K, Newman J, Ghani H, Munagala S, et al
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3.
Pulm Circ. 2026;16:e70256.
Abstract

QUYAM S, Drumm S, Mungala S, Bunclark K, et al
The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension.
Pulm Circ. 2026;16:e70269.
Abstract

BUNCLARK K, Newman J, Ghani H, Munagala S, et al
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life.
Pulm Circ. 2026;16:e70264.
Abstract

WANG E, Palaskas NL, Sahay S, Yu W, et al
Tumoural emboli syndromes case series: diagnostic dilemma in patients with cancer and pulmonary hypertension.
Eur Heart J Case Rep. 2026;10:ytag079.
Abstract

GILLEY J, Shivanna B
The relationship between cobalamin C deficiency and unexplained pediatric pulmonary hypertension.
Pediatr Res. 2026 Mar 3. doi: 10.1038/s41390-026-04899.
Abstract

EILON E, Lishinsky-Fischer N, Levy J
Response to: 'Comment on 'Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study".
Eye (Lond). 2026 Mar 3. doi: 10.1038/s41433-026-04379.
Abstract

MAN HJ, Zhao YD, Asghar U, Wu L, et al
Distinct endothelial cells in chronic thromboembolic pulmonary hypertension.
NPJ Cardiovasc Health. 2025;2:33.
Abstract

ZHAO D, Li Y, Yang Y, Yu F, et al
An optimized machine learning model based on hematological indicators for the noninvasive identification of baicalin's therapeutic effects in pulmonary hypertension.
Comput Methods Biomech Biomed Engin. 2026.
Abstract

WERNER RA, Higuchi T
In vivo targeting of fibroblast activation in chronic thromboembolic pulmonary hypertension: Ready for pulmonary prime time?
J Nucl Cardiol. 2026;56:102588.
Abstract

LIANG Q, Gou H, Zhu Y, He L, et al
Inhibiting the pathological changes of PASMCs is an effective approach for medicinal plants or secondary metabolites in treating pulmonary hypertension.
Front Pharmacol. 2026;17:1725809.
Abstract

MIRDAMADI A, Adib-Hajbagheri P
Misleading echocardiographic artifact mimicking severe pulmonary hypertension in a pregnant woman: A diagnostic challenge.
Respir Med Case Rep. 2026;60:102374.
Abstract

LIU BY, Yan WJ, Chen Y, Zhang HW, et al
The Prognostic Accuracy of Three-Dimensional Echocardiography in Patients With Pre-Capillary Pulmonary Hypertension.
Pulm Circ. 2026;16:e70260.
Abstract

NEVAREZ GILBERT AB, Bischoff AR
Pulmonary Hypertension in Infants Who Are Premature.
Neoreviews. 2026;27:e144-e156.
Abstract

RESQUETI V, Torres-Castro R, Gimeno-Santos E, Lopes Cardoso N, et al
Limitations of 6-minute walk test-based equations in predicting peak oxygen uptake and risk assessment in patients with pulmonary hypertension and COPD.
Respir Med. 2026;254:108738.
Abstract

VILLEGAS-ESGUEVILLAS M, Barreira B, Hernandez-Garcia A, Adao R, et al
The Sigma-1 receptor agonist PRE084 improves cardiopulmonary function and remodelling in an experimental model of pulmonary arterial hypertension.
Biomed Pharmacother. 2026;196:119115.
Abstract

GAO D, Song S, Gao Y, Zhu X, et al
Silencer-regulated circLSM14A inhibits autophagy of pulmonary artery smooth muscle cells through parental protein LSM14A.
Free Radic Biol Med. 2026;247:502-515.
Abstract

D'ALTO M, Scelsi L, Giuliani L, Perna GP, et al
Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO).
Vascul Pharmacol. 2026;162:107585.
Abstract

JOSE A, Elwing JM
Management of hepatopulmonary syndrome and portopulmonary hypertension.
Curr Opin Crit Care. 2026;32:187-192.
Abstract

QIAN X, Deng Y, Guo T, Huang X, et al
Plasma non-targeted metabolomics unveils the metabolic signatures of trans-right ventricle in pulmonary arterial hypertension associated with atrial septal defect.
Clin Chim Acta. 2026;584:120849.
Abstract

BOLAND E, Freeman MG, Corcoran DS, Ford TJ, et al
Coronary pathophysiology in idiopathic pulmonary arterial hypertension.
JCI Insight. 2026;11:e194613.
Abstract

CANTU-MARTINEZ O, Fudim M, Kong DF, Tedford RJ, et al
Accuracy of site versus core laboratory interpretations of right heart catheterization hemodynamics.
Am Heart J. 2026;295:107351.
Abstract

POLINI B, Ghelardoni S, Capone G, Monti E, et al
Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment.
Geroscience. 2026;48:2243-2266.
Abstract

WU SE, Mazurek JA, Mayeux JD, Habib NG, et al
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH).
Pulm Pharmacol Ther. 2026;92:102406.
Abstract

CHEN HM, Hou P, Liang SH, Guo WL, et al
The Prognostic Value of (18)F-FAPI PET/CT Imaging in Pulmonary Arterial Hypertension.
JACC Cardiovasc Imaging. 2026;19:363-374.
Abstract

SAGAR P, Thejaswi P, Karthikeyan M, Sivakumar K, et al
Custom-Fenestrated Atrial Septal Occluder Devices in Borderline Patients With Pulmonary Arterial Hypertension or Restrictive Left Ventricular Physiology.
Catheter Cardiovasc Interv. 2026;107:1156-1169.
Abstract

GARCIA DELGADO GM, Shammi UA, Thornburgh C, Ruppel M, et al
Dynamic RBC-To-Membrane Ratio in (129)Xe MRI: A Biomarker of Decreased Lung Function in Pulmonary and Vascular Diseases.
Magn Reson Med. 2026;95:2500-2507.
Abstract

MANZI G, Maggio E, Recchioni T, Adamo FI, et al
The pleiotropic effects of sotatercept.
Vascul Pharmacol. 2026;162:107577.
Abstract

RYAN JJ, Wilson M, Saggar R, Benninger C, et al
Expert consensus on patient engagement strategies for improving patient activation and shared decision making in pulmonary arterial hypertension.
J Am Assoc Nurse Pract. 2026;38:136-145.
Abstract

WONG JM, Lai E, Brent BN, Schiller NB, et al
Noninvasive Assessment of Mean Pulmonary Artery Pressure: A Comparison of Doppler Echocardiographic Methods.
J Am Soc Echocardiogr. 2026;39:294-303.
Abstract

QIU LH, Wang PR, Zhang K, Ning XH, et al
The application of partial pressure of oxygen adjusted indirect Fick method in vasoreactivity testing by inhaling oxygen in congenital heart disease.
Hypertens Res. 2026;49:874-882.
Abstract

XU H, Ye L, Du C, Tang H, et al
EP4/ANXA2 axis in pulmonary arterial hypertension: therapeutic implications.
Eur Heart J. 2025 Sep 25:ehaf763. doi: 10.1093.
Abstract

PEIXOTO J, Neto J, Pissarra S, Azevedo I, et al
Giant Omphalocele: Systematic Review of Pulmonary Complications and Implications for Neonatal Care.
Eur J Pediatr Surg. 2025 Jul 17. doi: 10.1055/a-2649-0781.
Abstract

SHEN Z, Huang D, Jia N, Zhao S, et al
Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis.
Biomed Pharmacother. 2023;167:115607.
Abstract

SOARES LL, Leite LB, Ervilha LOG, Pelozin BRA, et al
Resistance exercise training benefits pulmonary, cardiac, and muscular structure and function in rats with stable pulmonary artery hypertension.
Life Sci. 2023;332:122128.
Abstract

GUO WL, Hou P, Tan WG, Lei YX, et al
[A case of metastatic breast cancer complicated by pulmonary tumor thrombotic microangiopathy].
Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1014-1018.
Abstract

LI L, Xue Q, Zhang M, Yang Z, et al
Upregulation of the key biomarker kinesin family member 20A (KIF20A) is associated with pulmonary artery hypertension.
Genomics. 2023;115:110705.
Abstract

TAKAI A, Yamagishi M, Ikeda K, Sugimoto A, et al
Effectiveness of cardiac palliative surgery for trisomy 18 patients with increased pulmonary blood flow.
Am J Med Genet A. 2023;191:2703-2710.
Abstract

TAMURA Y, Kumamaru H, Nishimura S, Nakajima Y, et al
Initial Triple Combination Therapy Including Intravenous Prostaglandin I(2) for the Treatment of Patients with Severe Pulmonary Arterial Hypertension.
Int Heart J. 2023;64:684-692.
Abstract

RICHTER MJ, Douschan P, Fortuni F, Gall H, et al
Echocardiographic pressure-strain loop-derived stroke work of the right ventricle: validation against the gold standard.
ESC Heart Fail. 2023;10:3209-3215.
Abstract

BAGGA A, Astavans A, Goldin G, Everitt IK, et al
National Patterns of Pulmonary Hypertension Mortality in the United States, 2010-2024.
Am J Cardiol. 2026 Mar 3:S0002-9149(26)00117.
Abstract

OAKLAND HT, Bellumkonda L, Sugeng L, Joseph P, et al
3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension.
Am J Physiol Heart Circ Physiol. 2026;330:H729-H736.
Abstract

BHADRA A, Bonnie F, Hewes J, Patel M, et al
cAMP-enriched extracellular vesicles improve outcomes in pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol. 2026;330:L169-L177.
Abstract

MOOERS EA, Rana U, Joshi CN, Afolayan AJ, et al
Decreased AMP-Kinase Function in Pulmonary Artery Smooth Muscle Cells Contributes to Pulmonary Artery Remodeling in Persistent Pulmonary Hypertension of Newborn.
Am J Physiol Lung Cell Mol Physiol. 2026 Feb 25. doi: 10.1152/ajplung.00229.2025
Abstract

RICHALET JP, Jeny F, Callard P, Bernaudin JF, et al
High-altitude pulmonary edema: the intercellular network hypothesis.
Am J Physiol Lung Cell Mol Physiol. 2023;325:L155-L173.
Abstract

CHEN CN, Hajji N, Yeh FC, Rahman S, et al
Restoration of Foxp3(+) Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology.
Am J Respir Crit Care Med. 2023;208:879-895.
Abstract

ZAZZERON L, Mereto E, Lichtenegger P, Moore E, et al
Effects of continuous low-dose nitric oxide in a murine model of pulmonary hypertension with impaired lung development.
Anesthesiology. 2026 Jan 16. doi: 10.1097/ALN.0000000000005939.
Abstract

BIRD EM, Yang JZ, Mims EW, Kerr KM, et al
Safety and Immediate Efficacy of Pulmonary Thromboendarterectomy for Chronic Thromboembolic Disease.
Ann Thorac Surg. 2025 Jun 17:S0003-4975(25)00529.
Abstract

YANG JZ, Madani MM, Papamatheakis DG, Fernandes TM, et al
CHEST How I Do It: Management of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy.
Chest. 2026 Jan 2:S0012-3692(25)05963-X. doi: 10.1016/j.chest.2025.
Abstract

CELESTIN B, Bagherzadeh SP, Santana E, Frost M, et al
Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension.
Chest. 2026;169:207-219.
Abstract

CHANDEL A, Turkington S, King CS, Singhal A, et al
Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis.
Chest. 2026 Jan 27:S0012-3692(26)00127-3. doi: 10.1016/j.chest.2025.
Abstract

LANG IM
Chronic Thromboembolic Pulmonary Hypertension and Elevated Pulmonary Arterial Wedge Pressure: No Fear of BPA!
Chest. 2026;169:322-323.
Abstract

ROTER KW, Agrawal V
Decoding Exercise Pulmonary Hypertension: A Noninvasive Blueprint for Detection in Chronic Thromboembolic Pulmonary Disease.
Chest. 2026;169:584-585.
Abstract

JOHN T, Neuhuber L, Douschan P, Foris V, et al
The Clinical Relevance of Unclassified Pulmonary Hypertension.
Chest. 2026 Mar 9:S0012-3692(26)00275-8. doi: 10.1016/j.chest.2025.
Abstract

LAMMI MR, Khan SL, Rao Y, Zhao W, et al
The Minimal Important Difference in N-Terminal Pro-Brain Natriuretic Peptide in Pulmonary Hypertension.
Chest. 2026 Mar 7:S0012-3692(26)00287-4. doi: 10.1016/j.chest.2026.
Abstract

PRADHAN NM, Wessler BS, Hill N, Kurz S, et al
The Mitral Valve and The Lungs.
Chest. 2025 Nov 24:S0012-3692(25)05795-2. doi: 10.1016/j.chest.2025.
Abstract

BRONCANO J, Shifren A, Royuela J, Bhalla S, et al
Role of MRI in Interstitial Lung Diseases.
Chest. 2026;169:698-709.
Abstract

WANG AY, Ma JL, Cui Y, Qiu BC, et al
Growth Differentiation Factor-15 Improves Prognostic Accuracy of Risk Stratification in Pulmonary Arterial Hypertension.
Chest. 2026;169:758-768.
Abstract

ZAFEIROPOULOS S, Ahmed U, Bekiaridou A, Jayaprakash N, et al
Correction to: Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension.
Circ Res. 2026;138:e000740.
Abstract

SHEN Y, Bisserier M
ADAR1-Mediated RNA Editing Regulates Innate Immunity in Pulmonary Hypertension.
Circ Res. 2026;138:e327782.
Abstract

GUO S, Pan T, Yan X, Cheng Y, et al
Differential Impact of Recruited and Resident Macrophages on Hypoxia-Induced Pulmonary Hypertension.
Circ Res. 2025 Dec 31. doi: 10.1161/CIRCRESAHA.125.326472.
Abstract

JOKI Y, Konishi H, Takasu K, Katsuumi G, et al
Parathyroid Hormone Contributes to Pulmonary Hypertension in Hypoxic Conditions.
Circ Res. 2026 Mar 4. doi: 10.1161/CIRCRESAHA.125.327401.
Abstract

TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
Circulation. 2026 Jan 28. doi: 10.1161/CIRCULATIONAHA.125.079067.
Abstract

TADA A, Fayyaz AU, Reddy YNV, Redfield MM, et al
Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.
Circulation. 2026;153:285-289.
Abstract

REDDY YNV, Frantz RP, Miranda WR, Asokan AK, et al
Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.077606.
Abstract

BACCELLI A, Haji G, Tighe H, Howard LS, et al
Safety of Cardiopulmonary Exercise Testing in Pulmonary Hypertension: Insights from a UK Tertiary Referral Centre.
Eur Respir J. 2026 Jan 15:2502207. doi: 10.1183/13993003.02207-2025.
Abstract

YOGESWARAN A, Kremer NC, Tello K
Multi-beat right ventricular-pulmonary arterial coupling and survival in pulmonary hypertension: are we missing the right signals?
Eur Respir J. 2026;67:2502501.
Abstract

LIU C, Qiu BC, Li SP, Ma JS, et al
sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertension.
Eur Respir J. 2026 Jan 22:2502367. doi: 10.1183/13993003.02367-2025.
Abstract

REDDY YNV, Frantz RP, Miranda WR, Varma R, et al
Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension.
Eur Respir J. 2026 Feb 19:2501871. doi: 10.1183/13993003.01871-2025.
Abstract

JUTANT EM, Grynblat J, Pyrrait M, Lechartier B, et al
Pulmonary hypertension associated with hereditary hemorrhagic telangiectasia: from genetics to clinical management.
Eur Respir J. 2026 Feb 19:2502322. doi: 10.1183/13993003.02322-2025.
Abstract

RAGHU G, Sahay S, Price LC, Weatherald J, et al
Pulmonary Hypertension Associated With Interstitial Lung Disease: State-of-the-Art Review.
Eur Respir J. 2026 Mar 12:2502651. doi: 10.1183/13993003.02651-2025.
Abstract

KHAN MS, Borlaug BA, Butler J, Gomberg-Maitland M, et al
Pulmonary Hypertension Associated With Left Heart Disease: Challenges, Emerging Strategies, and Future Directions.
J Am Coll Cardiol. 2026 Mar 11:S0735-1097(26)00134.
Abstract

OLLOSU M, Tripodi VF, Aresu C, Ledda G, et al
Efficacy and Safety of Pulmonary Vasodilator and Inodilator Drugs in Congenital Heart Disease Surgery: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
J Cardiothorac Vasc Anesth. 2026;40:333-346.
Abstract

SARDO S, Tripodi VF, Guerzoni F, Musu M, et al
Pulmonary Vasodilator and Inodilator Drugs in Cardiac Surgery: A Systematic Review With Bayesian Network Meta-Analysis.
J Cardiothorac Vasc Anesth. 2023;37:2261-2271.
Abstract

SHIGEMURA N, Hage CA
Reframing Surgical Decision-Making When Treating Severe Pulmonary Hypertension: Beyond the Binary of Lungs Alone versus Combined Heart-Lung Transplantation.
J Heart Lung Transplant. 2025 Dec 20:S1053-2498(25)02466.
Abstract

DEWACHTER L, Vachiery JL
Same Pressure, Different Disease: A Proteomic Rethinking of Pulmonary Hypertension in Chronic Lung Disease.
J Heart Lung Transplant. 2026 Jan 13:S1053-2498(26)00008.
Abstract

TELLO K, Delcroix M, Pausch C, Huscher D, et al
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.
J Heart Lung Transplant. 2026;45:284-288.
Abstract

KREMER N, Glocker F, Schaefer S, Janetzko P, et al
Method for generating right ventricular pressure-volume loops in routine practice.
J Heart Lung Transplant. 2026;45:273-281.
Abstract

LUO D, Zheng X, Yang Z, Li H, et al
Machine learning for clustering and postclosure outcome of adult CHD-PAH patients with borderline hemodynamics.
J Heart Lung Transplant. 2023;42:1286-1297.
Abstract

GOPAGONDANAHALLI KR, Tan JM, Khoo May Lyn J, Sundararaghavan S, et al
Variable clinical and hemodynamic effect of sildenafil in extreme premature infants with bronchopulmonary dysplasia-associated pulmonary hypertension.
J Perinatol. 2026 Feb 5. doi: 10.1038/s41372-026-02578.
Abstract

FOOTE HP, Sun M, Goldstein BA, Hill KD, et al
Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia.
J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02576.
Abstract

RAMACHANDRA R, Arunamata A, Moy A, Tracy MC, et al
Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia.
J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02580.
Abstract

MORRIS H, Reilly M, Zhang H, Dong X, et al
Characteristics associated with death or tracheostomy in infants with bronchopulmonary dysplasia following predominant non-invasive respiratory support.
J Perinatol. 2025 Feb 22. doi: 10.1038/s41372-025-02234.
Abstract

BYRD CE, Wren JT Jr, Desiraju S, McNamara PJ, et al
A hemodynamic-driven approach to chronic pulmonary hypertension in congenital diaphragmatic hernia.
J Perinatol. 2026 Feb 23. doi: 10.1038/s41372-026-02582.
Abstract

SHENTU J, Dai W, Chen C, Huang J, et al
A Novel Rat Model for Group 2 Pulmonary Hypertension by Total Pulmonary Vein Banding: Multi-Omics Insights into Pathophysiological Mechanisms.
J Thorac Cardiovasc Surg. 2026 Jan 29:S0022-5223(26)00085.
Abstract

DUBROCK HM, Savale L, Sitbon O, Raevens S, et al
International Liver Transplantation Society practice guideline update on portopulmonary hypertension.
Liver Transpl. 2026;32:296-314.
Abstract

MINATSUKI S, Hatano M, Funakoshi K, Taniguchi Y, et al
Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension.
Thorax. 2026 Jan 7:thorax-2025-223670. doi: 10.1136/thorax-2025-223670.
Abstract

WU C, Wang Z, Luo Y, Sun H, et al
Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021 and projection to 2050: A systematic analysis for the global burden of disease study 2021.
PLoS One. 2025;20:e0338335.
Abstract

CHEN KL, Duemmel S, Christof M, Wang G, et al
Mixed effects of complement in a chronic murine model of inflammatory erosive arthritis and pulmonary vascular disease.
PLoS One. 2026;21:e0340677.
Abstract

OPATRIL L, Mojica-Pisciotti ML, Panovsky R, Machal J, et al
Comparison of pulmonary circulation parameters acquired by cardiovascular magnetic resonance with right heart catheterization and transthoracic echocardiography in patients with recent-onset dilated cardiomyopathy.
PLoS One. 2026;21:e0341438.
Abstract

CALE R, Ferreira F, Martinho M, Alegria S, et al
Residual physiological abnormalities after pulmonary endarterectomy and balloon pulmonary angioplasty in CTEPH.
PLoS One. 2026;21:e0344192.
Abstract

KAWAKAMI T, Hosokawa S, Ito M, Kurozumi A, et al
PAH-former: Transfer learning for efficient discovery of pulmonary arterial hypertension-associated genes.
PLoS One. 2026;21:e0344084.
Abstract

LEBENDER LF, Seidinger A, Matthey M, Dyck B, et al
Beta arrestin 1 is a key regulator of pulmonary vascular tone.
Proc Natl Acad Sci U S A. 2026;123:e2512602123.
Abstract

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum

;